{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:51:35Z","timestamp":1781653895000,"version":"3.54.5"},"reference-count":230,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270646"],"award-info":[{"award-number":["82270646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04483-2","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:05:35Z","timestamp":1777439135000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systems"],"prefix":"10.1186","volume":"24","author":[{"given":"Yanan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"2","key":"4483_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516\u201337. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.017. From NLM.","journal-title":"J Hepatol"},{"issue":"1","key":"4483_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhep.2023.01.026","volume":"79","author":"AM Allen","year":"2023","unstructured":"Allen AM, Lazarus JV, Younossi ZM. Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties. J Hepatol. 2023;79(1):209\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.026. From NLM.","journal-title":"J Hepatol"},{"issue":"5","key":"4483_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1136\/gutjnl-2024-332597","volume":"74","author":"P Lampertico","year":"2025","unstructured":"Lampertico P, Anolli MP, Roulot D, Wedemeyer H. Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies. Gut. 2025;74(5):853\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2024-332597. From NLM.","journal-title":"Gut"},{"issue":"7","key":"4483_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","volume":"20","author":"O Pabst","year":"2023","unstructured":"Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol. 2023;20(7):447\u201361. https:\/\/doi.org\/10.1038\/s41575-023-00771-6. From NLM.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"4483_CR5","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.cmet.2025.09.001","volume":"37","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Liu W, Wong CC, Song Q, Zhang X, Zhou Q, Ren X, Ren X, Xuan R, Zhao Y, et al. Catenibacteriummitsuokai promotes hepatocellular carcinogenesis by binding to hepatocytes and generating quinolinic acid. Cell Metab. 2025;37(10):1998\u2013e20131997. https:\/\/doi.org\/10.1016\/j.cmet.2025.09.001. From NLM.","journal-title":"Cell Metab"},{"issue":"12","key":"4483_CR6","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.cmet.2025.10.017","volume":"37","author":"X Long","year":"2025","unstructured":"Long X, Wang H, Lu Y, Gao X, Xiao Y, Zhang M, Guo J, Yang J, Zhang R, Li Q, et al. Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD. Cell Metab. 2025;37(12):2342\u2013e23612349. https:\/\/doi.org\/10.1016\/j.cmet.2025.10.017. From NLM.","journal-title":"Cell Metab"},{"issue":"21","key":"4483_CR7","doi-asserted-by":"publisher","first-page":"e2313953","DOI":"10.1002\/adma.202313953","volume":"36","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Li Q, Wu Y, Zhang W, Ding L, Ji C, Li P, Chen T, Feng L, Tang BZ, et al. Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy. Adv Mater. 2024;36(21):e2313953. https:\/\/doi.org\/10.1002\/adma.202313953. From NLM.","journal-title":"Adv Mater"},{"issue":"5","key":"4483_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/clpt.2012.143","volume":"92","author":"D Iusuf","year":"2012","unstructured":"Iusuf D, van de Steeg E, Schinkel AH. Hepatocyte hopping of OATP1B substrates contributes to efficient hepatic detoxification. Clin Pharmacol Ther. 2012;92(5):559\u201362. https:\/\/doi.org\/10.1038\/clpt.2012.143. From NLM.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4483_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41597-022-01676-w","volume":"9","author":"S Yu","year":"2022","unstructured":"Yu S, Wang H, Yang L, Yan Y, Cai Q, Ma D, Jiang L, Gao Z, Yu Z, Xia Z. Spatial transcriptome profiling of normal human liver. Sci Data. 2022;9(1):633. https:\/\/doi.org\/10.1038\/s41597-022-01676-w. From NLM.","journal-title":"Sci Data"},{"issue":"3","key":"4483_CR10","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jhep.2025.02.029","volume":"83","author":"H Wang","year":"2025","unstructured":"Wang H, Guo M, Ren B, Zhang H, Zhang J, Qiao R, Qian L, Zhu J, Zhang S, Su W, et al. Circadian control of hepatic ischemia\/reperfusion injury via HSD17B13-mediated autophagy in hepatocytes. J Hepatol. 2025;83(3):750\u201367. https:\/\/doi.org\/10.1016\/j.jhep.2025.02.029. From NLM.","journal-title":"J Hepatol"},{"key":"4483_CR11","doi-asserted-by":"publisher","first-page":"109231","DOI":"10.1016\/j.bioorg.2025.109231","volume":"167","author":"P Kumari","year":"2025","unstructured":"Kumari P, Kumar A, Bhatia R. Green and sustainable approaches to Quinazoline-based anticancer agents: Synthesis and structure activity relationship (SAR). Bioorg Chem. 2025;167:109231. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109231. From NLM.","journal-title":"Bioorg Chem"},{"key":"4483_CR12","doi-asserted-by":"publisher","first-page":"116166","DOI":"10.1016\/j.bcp.2024.116166","volume":"228","author":"JJG Marin","year":"2024","unstructured":"Marin JJG, Cives-Losada C, Macias RIR, Romero MR, Marijuan RP, Hortelano-Hernandez N, Delgado-Calvo K, Villar C, Gonzalez-Santiago JM, Monte MJ, et al. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition. Biochem Pharmacol. 2024;228:116166. https:\/\/doi.org\/10.1016\/j.bcp.2024.116166. From NLM.","journal-title":"Biochem Pharmacol"},{"issue":"10515","key":"4483_CR13","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/s0140-6736(25)01720-9","volume":"406","author":"Z Wang","year":"2025","unstructured":"Wang Z, Fan J, Zhou S, Sun Y, Liang F, Ji Y, Gu F, Li T, Peng L, Peng T, et al. Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2\/3 trial. Lancet. 2025;406(10515):2089\u201399. https:\/\/doi.org\/10.1016\/s0140-6736(25)01720-9. From NLM.","journal-title":"Lancet"},{"key":"4483_CR14","doi-asserted-by":"publisher","unstructured":"Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012, 75 (3), 311\u2013335. https:\/\/doi.org\/10.1021\/np200906s From NLM.","DOI":"10.1021\/np200906s"},{"key":"4483_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-025-10617-z","author":"S Rudnyckyj","year":"2025","unstructured":"Rudnyckyj S, Thomsen MH. Probiotics and Postbiotics Derived from Saline\/Marine Plant-Based Feedstocks. Probiotics Antimicrob Proteins. 2025. https:\/\/doi.org\/10.1007\/s12602-025-10617-z. From NLM.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4483_CR16","doi-asserted-by":"publisher","first-page":"115851","DOI":"10.1016\/j.fct.2025.115851","volume":"207","author":"J Wang","year":"2025","unstructured":"Wang J, Liu Y, Zhu C, Wang Z, Wang S, Fang S, Xu F. Gut microbiota and immune regulation by Lactobacillus delbrueckii subsp. bulgaricus LB42: From preclinical safety assessment to clinical evidence. Food Chem Toxicol. 2025;207:115851. https:\/\/doi.org\/10.1016\/j.fct.2025.115851. From NLM.","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"4483_CR17","doi-asserted-by":"publisher","first-page":"2172671","DOI":"10.1080\/19490976.2023.2172671","volume":"15","author":"AB Larabi","year":"2023","unstructured":"Larabi AB, Masson HLP, B\u00e4umler AJ. Bile acids as modulators of gut microbiota composition and function. Gut Microbes. 2023;15(1):2172671. https:\/\/doi.org\/10.1080\/19490976.2023.2172671. From NLM.","journal-title":"Gut Microbes"},{"issue":"3","key":"4483_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/femsre\/fuaa010","volume":"44","author":"CB Wong","year":"2020","unstructured":"Wong CB, Odamaki T, Xiao JZ. Insights into the reason of Human-Residential Bifidobacteria (HRB) being the natural inhabitants of the human gut and their potential health-promoting benefits. FEMS Microbiol Rev. 2020;44(3):369\u201385. https:\/\/doi.org\/10.1093\/femsre\/fuaa010. From NLM.","journal-title":"FEMS Microbiol Rev"},{"key":"4483_CR19","doi-asserted-by":"publisher","unstructured":"Nishiyama K, Yamamoto Y, Sugiyama M, Takaki T, Urashima T, Fukiya S, Yokota A, Okada N, Mukai T. Bifidobacterium bifidum Extracellular Sialidase Enhances Adhesion to the Mucosal Surface and Supports Carbohydrate Assimilation. mBio. 2017;8(5). https:\/\/doi.org\/10.1128\/mBio.00928-17. From NLM.","DOI":"10.1128\/mBio.00928-17"},{"key":"4483_CR20","doi-asserted-by":"publisher","first-page":"1219763","DOI":"10.3389\/fmicb.2023.1219763","volume":"14","author":"J Shi","year":"2023","unstructured":"Shi J, Ma D, Gao S, Long F, Wang X, Pu X, Cannon RD, Han TL. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles modulate the intestinal microbiome and host gut-liver metabolome in obese and diabetic mice. Front Microbiol. 2023;14:1219763. https:\/\/doi.org\/10.3389\/fmicb.2023.1219763. From NLM.","journal-title":"Front Microbiol"},{"key":"4483_CR21","doi-asserted-by":"crossref","unstructured":"Schultz M, Burton JP. Chapter 5 - Escherichia coli Nissle 1917. In: Floch MH, Ringel Y, Walker A, editors. The Microbiota in Gastrointestinal Pathophysiology. W. Eds.; Academic Press. 2017. pp. 59\u201369.","DOI":"10.1016\/B978-0-12-804024-9.00005-7"},{"issue":"1","key":"4483_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12934-025-02818-6","volume":"24","author":"ZY Liu","year":"2025","unstructured":"Liu ZY, Yu XZ. Engineering Bacillus subtilis for high-value bioproduction: recent advances and applications. Microb Cell Fact. 2025;24(1):182. https:\/\/doi.org\/10.1186\/s12934-025-02818-6. From NLM.","journal-title":"Microb Cell Fact"},{"key":"4483_CR23","doi-asserted-by":"publisher","unstructured":"Bashir S, Sadaf S, Ahmad S, Akhtar MW. Enhanced and Secretory Expression of Human Granulocyte Colony Stimulating Factor by Bacillus subtilis SCK6. Biomed Res Int. 2015;2015(636249). https:\/\/doi.org\/10.1155\/2015\/636249. From NLM.","DOI":"10.1155\/2015\/636249"},{"issue":"1","key":"4483_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biotechadv.2006.08.002","volume":"25","author":"F Ling Lin","year":"2007","unstructured":"Ling Lin F, Zi Rong X, Wei Fen L, Jiang Bing S, Ping L, Chun Xia H. Protein secretion pathways in Bacillus subtilis: implication for optimization of heterologous protein secretion. Biotechnol Adv. 2007;25(1):1\u201312. https:\/\/doi.org\/10.1016\/j.biotechadv.2006.08.002. From NLM.","journal-title":"Biotechnol Adv"},{"key":"4483_CR25","doi-asserted-by":"publisher","unstructured":"Kotowska M, Albrecht P, Szajewska H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005, 21 (5), 583\u2013590. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02356.x From NLM.","DOI":"10.1111\/j.1365-2036.2005.02356.x"},{"key":"4483_CR26","doi-asserted-by":"publisher","first-page":"887728","DOI":"10.3389\/fmicb.2022.887728","volume":"13","author":"AM Yang","year":"2022","unstructured":"Yang AM, Lin CY, Liu SH, Syu GD, Sun HJ, Lee KC, Lin HC, Hou MC. Saccharomyces Boulardii Ameliorates Non-alcoholic Steatohepatitis in Mice Induced by a Methionine-Choline-Deficient Diet Through Gut-Liver Axis. Front Microbiol. 2022;13:887728. https:\/\/doi.org\/10.3389\/fmicb.2022.887728. From NLM.","journal-title":"Front Microbiol"},{"issue":"2","key":"4483_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2021.12.001","volume":"40","author":"HN Bell","year":"2022","unstructured":"Bell HN, Rebernick RJ, Goyert J, Singhal R, Kuljanin M, Kerk SA, Huang W, Das NK, Andren A, Solanki S, et al. Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance. Cancer Cell. 2022;40(2):185\u2013e200186. https:\/\/doi.org\/10.1016\/j.ccell.2021.12.001. From NLM.","journal-title":"Cancer Cell"},{"issue":"4","key":"4483_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/19490976.2020.1734423","volume":"11","author":"H Wu","year":"2020","unstructured":"Wu H, Xie S, Miao J, Li Y, Wang Z, Wang M, Yu Q. Lactobacillus reuteri maintains intestinal epithelial regeneration and repairs damaged intestinal mucosa. Gut Microbes. 2020;11(4):997\u20131014. https:\/\/doi.org\/10.1080\/19490976.2020.1734423. From NLM.","journal-title":"Gut Microbes"},{"issue":"3","key":"4483_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/gmic.20169","volume":"3","author":"F Fouhy","year":"2012","unstructured":"Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes. 2012;3(3):203\u201320. https:\/\/doi.org\/10.4161\/gmic.20169. From NLM.","journal-title":"Gut Microbes"},{"key":"4483_CR30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fmicb.2017.00478","volume":"8","author":"S Dhanashree; Rajashekharan","year":"2017","unstructured":"Dhanashree; Rajashekharan S, Krishnaswamy B, Kammara R. Bifid Shape Is Intrinsic to Bifidobacterium adolescentis. Front Microbiol. 2017;8:478. https:\/\/doi.org\/10.3389\/fmicb.2017.00478. From NLM.","journal-title":"Front Microbiol"},{"issue":"6","key":"4483_CR31","doi-asserted-by":"publisher","first-page":"126273","DOI":"10.1016\/j.syapm.2021.126273","volume":"44","author":"GA Lugli","year":"2021","unstructured":"Lugli GA, Calvete-Torre I, Alessandri G, Milani C, Turroni F, Laiolo P, Ossiprandi MC, Margolles A, Ruiz L, Ventura M. Phylogenetic classification of ten novel species belonging to the genus Bifidobacterium comprising B. phasiani sp. nov., B. pongonis sp. nov., B. saguinibicoloris sp. nov., B. colobi sp. nov., B. simiiventris sp. nov., B. santillanense sp. nov., B. miconis sp. nov., B. amazonense sp. nov., B. pluvialisilvae sp. nov., and B. miconisargentati sp. nov. Syst Appl Microbiol. 2021;44(6):126273. https:\/\/doi.org\/10.1016\/j.syapm.2021.126273. From NLM.","journal-title":"Syst Appl Microbiol"},{"issue":"11","key":"4483_CR32","doi-asserted-by":"publisher","first-page":"101798","DOI":"10.1016\/j.xcrm.2024.101798","volume":"5","author":"X Qian","year":"2024","unstructured":"Qian X, Li Q, Zhu H, Chen Y, Lin G, Zhang H, Chen W, Wang G, Tian P. Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation. Cell Rep Med. 2024;5(11):101798. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101798. From NLM Medline.","journal-title":"Cell Rep Med"},{"key":"4483_CR33","doi-asserted-by":"publisher","unstructured":"Duranti S, Gaiani F, Mancabelli L, Milani C, Grandi A, Bolchi A, Santoni A, Lugli GA, Ferrario C, Mangifesta M, et al. Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers. FEMS Microbiol Ecol. 2016;92(12). https:\/\/doi.org\/10.1093\/femsec\/fiw191. From NLM.","DOI":"10.1093\/femsec\/fiw191"},{"key":"4483_CR34","doi-asserted-by":"publisher","unstructured":"Itoh K, Matsueda S. Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions. Biomedicines. 2024;12(4). https:\/\/doi.org\/10.3390\/biomedicines12040803. From NLM.","DOI":"10.3390\/biomedicines12040803"},{"key":"4483_CR35","doi-asserted-by":"publisher","first-page":"116840","DOI":"10.1016\/j.foodres.2025.116840","volume":"217","author":"Y Shan","year":"2025","unstructured":"Shan Y, Zheng M, Liang W, Ouyang L, Wang S. 2\u2019-Fucosyllactose synbiotics with Bifidobacterium bifidum to improve intestinal transcriptional function and gut microbiota in constipated mice. Food Res Int. 2025;217:116840. https:\/\/doi.org\/10.1016\/j.foodres.2025.116840. From NLM.","journal-title":"Food Res Int"},{"issue":"2","key":"4483_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijfoodmicro.2006.05.017","volume":"113","author":"M Gueimonde","year":"2007","unstructured":"Gueimonde M, Margolles A, de los Reyes-Gavil\u00e1n CG, Salminen S. Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile\u2013a preliminary study. Int J Food Microbiol. 2007;113(2):228\u201332. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2006.05.017. From NLM.","journal-title":"Int J Food Microbiol"},{"key":"4483_CR37","doi-asserted-by":"publisher","unstructured":"Markowiak P, Slizewska K. Effects of Probiotics, Prebiotics, and Synbiotics on Human Health. Nutrients. 2017;9(9). https:\/\/doi.org\/10.3390\/nu9091021. From NLM Medline.","DOI":"10.3390\/nu9091021"},{"issue":"5","key":"4483_CR38","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1007\/s12602-024-10232-4","volume":"17","author":"JJ Jeong","year":"2025","unstructured":"Jeong JJ, Jin YJ, Ganesan R, Park HJ, Min BH, Jeong MK, Yoon SJ, Choi MR, Sharma SP, Jang YJ, et al. Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway. Probiotics Antimicrob Proteins. 2025;17(5):2894\u2013908. https:\/\/doi.org\/10.1007\/s12602-024-10232-4. From NLM Medline.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4483_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-025-10763-4","author":"Y Che","year":"2025","unstructured":"Che Y, Shi Y, Xu Y, Guo S, Liu H, Yang J, Liu J, Niu J, Shi W, Guo L, et al. Gut Microbiota Dysbiosis and LPS\/NLRP3\/GSDMD Pyroptosis Drive Hepatic Fibrosis: Therapeutic Potential of a Synbiotic Intervention. Probiotics Antimicrob Proteins. 2025. https:\/\/doi.org\/10.1007\/s12602-025-10763-4. From NLM Publisher.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4483_CR40","doi-asserted-by":"publisher","first-page":"108030","DOI":"10.1016\/j.phrs.2025.108030","volume":"222","author":"JY Lu","year":"2025","unstructured":"Lu JY, Zuo HT, Feng R, Chen YL, Ye ML, Xu H, Hu JC, Song JY, Zhao Y, Wang JY, et al. Parishin A reduces hepatic encephalopathy via gut microbiota increasing the activity of intestinal EAAT3 to reduce blood ammonia. Pharmacol Res. 2025;222:108030. https:\/\/doi.org\/10.1016\/j.phrs.2025.108030. From NLM.","journal-title":"Pharmacol Res"},{"key":"4483_CR41","doi-asserted-by":"publisher","first-page":"1666866","DOI":"10.3389\/fimmu.2025.1666866","volume":"16","author":"J Yang","year":"2025","unstructured":"Yang J, Huang Q, Long J, Li J. Microbiota and inflammatory bowel disease: the dual effect mechanism of polysaccharide therapy. Front Immunol. 2025;16:1666866. https:\/\/doi.org\/10.3389\/fimmu.2025.1666866. From NLM.","journal-title":"Front Immunol"},{"issue":"1","key":"4483_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40168-025-02133-7","volume":"13","author":"Z Zhou","year":"2025","unstructured":"Zhou Z, Niu Y, Ma Y, Zhang D, Wang Y, Ji R, Zhao J, Ma C, Zhu H, Liu Y, et al. Lipid accumulation inhibition strategies alleviate Fusobacterium nucleatum-infected colorectal cancer. Microbiome. 2025;13(1):181. https:\/\/doi.org\/10.1186\/s40168-025-02133-7. From NLM.","journal-title":"Microbiome"},{"issue":"6","key":"4483_CR43","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","volume":"79","author":"Q Song","year":"2023","unstructured":"Song Q, Zhang X, Liu W, Wei H, Liang W, Zhou Y, Ding Y, Ji F, Ho-Kwan Cheung A, Wong N, et al. Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma. J Hepatol. 2023;79(6):1352\u201365. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.005. From NLM.","journal-title":"J Hepatol"},{"issue":"1","key":"4483_CR44","doi-asserted-by":"publisher","first-page":"114407","DOI":"10.1016\/j.yexcr.2025.114407","volume":"445","author":"J Xu","year":"2025","unstructured":"Xu J, Wu X, Yang L, Xu X. The intervention of B. longum metabolites in Fnevs\u2019 carcinogenic capacity: A potential double-edged sword. Exp Cell Res. 2025;445(1):114407. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114407. From NLM.","journal-title":"Exp Cell Res"},{"issue":"2","key":"4483_CR45","doi-asserted-by":"publisher","first-page":"2291164","DOI":"10.1080\/19490976.2023.2291164","volume":"15","author":"SJ Gavzy","year":"2023","unstructured":"Gavzy SJ, Kensiski A, Lee ZL, Mongodin EF, Ma B, Bromberg JS. Bifidobacterium mechanisms of immune modulation and tolerance. Gut Microbes. 2023;15(2):2291164. https:\/\/doi.org\/10.1080\/19490976.2023.2291164. From NLM.","journal-title":"Gut Microbes"},{"issue":"2","key":"4483_CR46","doi-asserted-by":"publisher","first-page":"2281015","DOI":"10.1080\/19490976.2023.2281015","volume":"15","author":"A Beau","year":"2023","unstructured":"Beau A, Benoit B, Le Barz M, Meugnier E, Penhoat A, Calzada C, Pinteur C, Loizon E, Chanon S, Vieille-Marchiset A, et al. Inhibition of intestinal FXR activity as a possible mechanism for the beneficial effects of a probiotic mix supplementation on lipid metabolism alterations and weight gain in mice fed a high fat diet. Gut Microbes. 2023;15(2):2281015. https:\/\/doi.org\/10.1080\/19490976.2023.2281015. From NLM.","journal-title":"Gut Microbes"},{"issue":"5","key":"4483_CR47","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1021\/acs.jafc.3c05709","volume":"72","author":"X Liang","year":"2024","unstructured":"Liang X, Zheng X, Wang P, Zhang H, Ma Y, Liang H, Zhang Z. Bifidobacterium animalis subsp. lactis F1-7 Alleviates Lipid Accumulation in Atherosclerotic Mice via Modulating Bile Acid Metabolites to Downregulate Intestinal FXR. J Agric Food Chem. 2024;72(5):2585\u201397. https:\/\/doi.org\/10.1021\/acs.jafc.3c05709. From NLM.","journal-title":"J Agric Food Chem"},{"key":"4483_CR48","doi-asserted-by":"crossref","unstructured":"Do MH, Oh MJ, Lee HB, Kang CH, Yoo G, Park HY. Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines. Nutrients 2022, 14 (9). DOI: 10.3390\/nu14091965IF: 5.0 Q1 B2 From NLM.","DOI":"10.3390\/nu14091965"},{"issue":"7\u20138","key":"4483_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijmm.2012.09.004","volume":"302","author":"A Troge","year":"2012","unstructured":"Troge A, Scheppach W, Schroeder BO, Rund SA, Heuner K, Wehkamp J, Stange EF, Oelschlaeger TA. More than a marine propeller\u2013the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. Int J Med Microbiol. 2012;302(7\u20138):304\u201314. https:\/\/doi.org\/10.1016\/j.ijmm.2012.09.004. From NLM.","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"4483_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1857514","volume":"13","author":"YA Helmy","year":"2021","unstructured":"Helmy YA, Kassem II, Rajashekara G. Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection. Gut Microbes. 2021;13(1):1\u201316. https:\/\/doi.org\/10.1080\/19490976.2020.1857514. From NLM.","journal-title":"Gut Microbes"},{"issue":"4","key":"4483_CR51","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00431-007-0419-x","volume":"166","author":"J Henker","year":"2007","unstructured":"Henker J, Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, Wolff C, Schulze J. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur J Pediatr. 2007;166(4):311\u20138. https:\/\/doi.org\/10.1007\/s00431-007-0419-x. From NLM.","journal-title":"Eur J Pediatr"},{"key":"4483_CR52","doi-asserted-by":"publisher","unstructured":"Alvarez CS, Badia J, Bosch M, Gim\u00e9nez R, Baldom\u00e0 L. Outer Membrane Vesicles and Soluble Factors Released by Probiotic Escherichia coli Nissle 1917 and Commensal ECOR63 Enhance Barrier Function by Regulating Expression of Tight Junction Proteins in Intestinal Epithelial Cells. Front Microbiol 2016, 7, 1981. https:\/\/doi.org\/10.3389\/fmicb.2016.01981 From NLM.","DOI":"10.3389\/fmicb.2016.01981"},{"issue":"7","key":"4483_CR53","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/iai.01449-05","volume":"74","author":"A Grabig","year":"2006","unstructured":"Grabig A, Paclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, et al. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun. 2006;74(7):4075\u201382. https:\/\/doi.org\/10.1128\/iai.01449-05. From NLM.","journal-title":"Infect Immun"},{"key":"4483_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ymben.2024.10.002","volume":"86","author":"R Sun","year":"2024","unstructured":"Sun R, Yu P, Guo L, Huang Y, Nie Y, Yang Y. Improving the growth and intestinal colonization of Escherichia coli Nissle 1917 by strengthening its oligopeptides importation ability. Metab Eng. 2024;86:157\u201371. https:\/\/doi.org\/10.1016\/j.ymben.2024.10.002. From NLM.","journal-title":"Metab Eng"},{"issue":"7632","key":"4483_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nature20557","volume":"540","author":"M Sassone-Corsi","year":"2016","unstructured":"Sassone-Corsi M, Nuccio SP, Liu H, Hernandez D, Vu CT, Takahashi AA, Edwards RA, Raffatellu M. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature. 2016;540(7632):280\u20133. https:\/\/doi.org\/10.1038\/nature20557. From NLM.","journal-title":"Nature"},{"key":"4483_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03801-4","author":"J Chen","year":"2025","unstructured":"Chen J, Kong R, Qiu Y, Chen S, Liu Y, Yu X, Yang X, Zhang Y, Zhu Y. Improving T cell expansion by optogenetically engineered bacteria-loaded MMP-2-responsive cyclophosphamide for antitumor immunotherapy. J Nanobiotechnol. 2025. https:\/\/doi.org\/10.1186\/s12951-025-03801-4. From NLM.","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"4483_CR57","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/HEP.0000000000000987","volume":"83","author":"G Parthasarathy","year":"2026","unstructured":"Parthasarathy G, Malhi H, Bajaj JS. Therapeutic manipulation of the microbiome in liver disease. Hepatology. 2026;83(4):948\u201369. 1097\/HEP.0000000000000987 From NLM Medline.","journal-title":"Hepatology"},{"key":"4483_CR58","doi-asserted-by":"publisher","unstructured":"Thiruvengadam R, Gandhi K, Vaithiyanathan S, Sankarasubramanian H, Loganathan K, Lingan R, Rajagopalan VR, Muthurajan R, Ebenezer Iyadurai J, Kuppusami P. Complete Genome Sequence Analysis of Bacillus subtilis Bbv57, a Promising Biocontrol Agent against Phytopathogens. Int J Mol Sci. 2022;23(17). https:\/\/doi.org\/10.3390\/ijms23179732. From NLM.","DOI":"10.3390\/ijms23179732"},{"issue":"6","key":"4483_CR59","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/1751-7915.14257","volume":"16","author":"E Bremer","year":"2023","unstructured":"Bremer E, Calteau A, Danchin A, Harwood C, Helmann JD, M\u00e9digue C, Palsson BO, Sekowska A, Vallenet D, Zuniga A, et al. A model industrial workhorse: Bacillus subtilis strain 168 and its genome after a quarter of a century. Microb Biotechnol. 2023;16(6):1203\u201331. https:\/\/doi.org\/10.1111\/1751-7915.14257. From NLM.","journal-title":"Microb Biotechnol"},{"issue":"1","key":"4483_CR60","doi-asserted-by":"publisher","first-page":"13151","DOI":"10.1038\/s41598-019-49688-8","volume":"9","author":"T Yu","year":"2019","unstructured":"Yu T, Kong J, Zhang L, Gu X, Wang M, Guo T. New crosstalk between probiotics Lactobacillus plantarum and Bacillus subtilis. Sci Rep. 2019;9(1):13151. https:\/\/doi.org\/10.1038\/s41598-019-49688-8. From NLM.","journal-title":"Sci Rep"},{"key":"4483_CR61","doi-asserted-by":"publisher","first-page":"715863","DOI":"10.3389\/fmicb.2021.715863","volume":"12","author":"J Colom","year":"2021","unstructured":"Colom J, Freitas D, Simon A, Brodkorb A, Buckley M, Deaton J, Winger AM. Presence and Germination of the Probiotic Bacillus subtilis DE111(\u00ae) in the Human Small Intestinal Tract: A Randomized, Crossover, Double-Blind, and Placebo-Controlled Study. Front Microbiol. 2021;12:715863. https:\/\/doi.org\/10.3389\/fmicb.2021.715863. From NLM.","journal-title":"Front Microbiol"},{"issue":"3","key":"4483_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/mmbr.64.3.548-572.2000","volume":"64","author":"WL Nicholson","year":"2000","unstructured":"Nicholson WL, Munakata N, Horneck G, Melosh HJ, Setlow P. Resistance of Bacillus endospores to extreme terrestrial and extraterrestrial environments. Microbiol Mol Biol Rev. 2000;64(3):548\u201372. https:\/\/doi.org\/10.1128\/mmbr.64.3.548-572.2000. From NLM.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"7728","key":"4483_CR63","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-018-0616-y","volume":"562","author":"P Piewngam","year":"2018","unstructured":"Piewngam P, Zheng Y, Nguyen TH, Dickey SW, Joo HS, Villaruz AE, Glose KA, Fisher EL, Hunt RL, Li B, et al. Pathogen elimination by probiotic Bacillus via signalling interference. Nature. 2018;562(7728):532\u20137. https:\/\/doi.org\/10.1038\/s41586-018-0616-y. From NLM.","journal-title":"Nature"},{"issue":"6","key":"4483_CR64","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1163\/18762891-bja00028","volume":"15","author":"F Mourey","year":"2024","unstructured":"Mourey F, Scholtens P, Jeanne JF, Rodriguez B, Decherf A, Machuron F, Kardinaal A, Scheithauer T, Porbahaie M, Narni-Mancinelli E, et al. The probiotic strain Bacillus subtilis CU1 primes antimicrobial innate immune response and reduces low-grade inflammation: a clinical study. Benef Microbes. 2024;15(6):659\u201378. https:\/\/doi.org\/10.1163\/18762891-bja00028. From NLM.","journal-title":"Benef Microbes"},{"issue":"1","key":"4483_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12917-020-02468-3","volume":"16","author":"Y Oh","year":"2020","unstructured":"Oh Y, Kim JA, Kim CH, Choi SK, Pan JG. Bacillus subtilis spore vaccines displaying protective antigen induce functional antibodies and protective potency. BMC Vet Res. 2020;16(1):259. https:\/\/doi.org\/10.1186\/s12917-020-02468-3. From NLM.","journal-title":"BMC Vet Res"},{"key":"4483_CR66","doi-asserted-by":"publisher","first-page":"162727","DOI":"10.1016\/j.cej.2025.162727","volume":"512","author":"J Chen","year":"2025","unstructured":"Chen J, Wei C, Pan C, Wei Y, Li B, Liu T, Wang X, Wen Z, Zhao Y, Zhang M, et al. Genetically engineered Bacillus subtilis-derived extracellular vesicles Alleviates Ulcerative colitis by restoring intestinal barrier and regulating gut microbiota. Chem Eng J. 2025;512:162727. https:\/\/doi.org\/10.1016\/j.cej.2025.162727.","journal-title":"Chem Eng J"},{"issue":"1","key":"4483_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13567-024-01438-z","volume":"56","author":"W Li","year":"2025","unstructured":"Li W, Wang X, Chen K, Zhu Y, Yang G, Jin Y, Wang J. Engineered Bacillus subtilis WB600\/ZD prevents Salmonella Infantis-induced intestinal inflammation and alters the colon microbiota in a mouse model. Vet Res. 2025;56(1):35. https:\/\/doi.org\/10.1186\/s13567-024-01438-z. From NLM.","journal-title":"Vet Res"},{"issue":"13","key":"4483_CR68","doi-asserted-by":"publisher","first-page":"111416","DOI":"10.1016\/j.celrep.2022.111416","volume":"40","author":"Q Hou","year":"2022","unstructured":"Hou Q, Jia J, Lin J, Zhu L, Xie S, Yu Q, Li Y. Bacillus subtilis programs the differentiation of intestinal secretory lineages to inhibit Salmonella infection. Cell Rep. 2022;40(13):111416. https:\/\/doi.org\/10.1016\/j.celrep.2022.111416. From NLM.","journal-title":"Cell Rep"},{"key":"4483_CR69","doi-asserted-by":"publisher","first-page":"111675","DOI":"10.1016\/j.intimp.2024.111675","volume":"130","author":"Q Wang","year":"2024","unstructured":"Wang Q, Wang F, Tang L, Wang Y, Zhou Y, Li X, Jin M, Fu A, Li W. Bacillus amyloliquefaciens SC06 alleviated intestinal damage induced by inflammatory via modulating intestinal microbiota and intestinal stem cell proliferation and differentiation. Int Immunopharmacol. 2024;130:111675. https:\/\/doi.org\/10.1016\/j.intimp.2024.111675. From NLM.","journal-title":"Int Immunopharmacol"},{"key":"4483_CR70","doi-asserted-by":"publisher","first-page":"153487","DOI":"10.1016\/j.tox.2023.153487","volume":"488","author":"S Wang","year":"2023","unstructured":"Wang S, Liu J, Cheng D, Ren L, Zheng L, Chen F, Zeng T. Bacillus subtilis pretreatment alleviates ethanol-induced acute liver injury by regulating the Gut-liver axis in mice. Toxicology. 2023;488:153487. https:\/\/doi.org\/10.1016\/j.tox.2023.153487. From NLM Medline.","journal-title":"Toxicology"},{"key":"4483_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-025-10634-y","author":"TY Ting","year":"2025","unstructured":"Ting TY, Lee WJ, Goh HH. Molecular Genetics and Probiotic Mechanisms of Saccharomyces cerevisiae var. boulardii. Probiotics Antimicrob Proteins. 2025. https:\/\/doi.org\/10.1007\/s12602-025-10634-y. From NLM.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4483_CR72","doi-asserted-by":"publisher","unstructured":"Xiang Q, Wu X, Pan Y, Wang L, Cui C, Guo Y, Zhu L, Peng J, Wei H. Early-Life Intervention Using Fecal Microbiota Combined with Probiotics Promotes Gut Microbiota Maturation, Regulates Immune System Development, and Alleviates Weaning Stress in Piglets. Int J Mol Sci. 2020;21(2). https:\/\/doi.org\/10.3390\/ijms21020503. From NLM.","DOI":"10.3390\/ijms21020503"},{"key":"4483_CR73","doi-asserted-by":"publisher","first-page":"1204122","DOI":"10.3389\/fmicb.2023.1204122","volume":"14","author":"H Gao","year":"2023","unstructured":"Gao H, Li Y, Xu J, Zuo X, Yue T, Xu H, Sun J, Wang M, Ye T, Yu Y, et al. Saccharomyces boulardii protects against murine experimental colitis by reshaping the gut microbiome and its metabolic profile. Front Microbiol. 2023;14:1204122. https:\/\/doi.org\/10.3389\/fmicb.2023.1204122. From NLM.","journal-title":"Front Microbiol"},{"issue":"4","key":"4483_CR74","doi-asserted-by":"publisher","first-page":"e0078023","DOI":"10.1128\/spectrum.00780-23","volume":"11","author":"J Kim","year":"2023","unstructured":"Kim J, Atkinson C, Miller MJ, Kim KH, Jin YS. Microbiome Engineering Using Probiotic Yeast: Saccharomyces boulardii and the Secreted Human Lysozyme Lead to Changes in the Gut Microbiome and Metabolome of Mice. Microbiol Spectr. 2023;11(4):e0078023. https:\/\/doi.org\/10.1128\/spectrum.00780-23. From NLM.","journal-title":"Microbiol Spectr"},{"key":"4483_CR75","doi-asserted-by":"publisher","first-page":"107372","DOI":"10.1016\/j.phrs.2024.107372","volume":"208","author":"X Qin","year":"2024","unstructured":"Qin X, Zhao Q, Zhao Q, Yang L, Li W, Wu J, Liu T, Zhong W, Jiang K, Liu W, et al. A Saccharomyces boulardii-derived antioxidant protein, thioredoxin, ameliorates intestinal inflammation through transactivating epidermal growth factor receptor. Pharmacol Res. 2024;208:107372. https:\/\/doi.org\/10.1016\/j.phrs.2024.107372. From NLM.","journal-title":"Pharmacol Res"},{"issue":"1","key":"4483_CR76","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1038\/s41467-024-48128-0","volume":"15","author":"MK Heavey","year":"2024","unstructured":"Heavey MK, Hazelton A, Wang Y, Garner M, Anselmo AC, Arthur JC, Nguyen J. Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis. Nat Commun. 2024;15(1):3784. https:\/\/doi.org\/10.1038\/s41467-024-48128-0. From NLM.","journal-title":"Nat Commun"},{"issue":"1","key":"4483_CR77","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1039\/d1fo02752b","volume":"13","author":"B Li","year":"2022","unstructured":"Li B, Zhang H, Shi L, Li R, Luo Y, Deng Y, Li S, Li R, Liu Z. Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice. Food Funct. 2022;13(1):102\u201312. https:\/\/doi.org\/10.1039\/d1fo02752b. From NLM.","journal-title":"Food Funct"},{"key":"4483_CR78","doi-asserted-by":"publisher","first-page":"106022","DOI":"10.1016\/j.phrs.2021.106022","volume":"175","author":"B Cui","year":"2022","unstructured":"Cui B, Lin L, Wang B, Liu W, Sun C. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer? Pharmacol Res. 2022;175:106022. https:\/\/doi.org\/10.1016\/j.phrs.2021.106022. From NLM.","journal-title":"Pharmacol Res"},{"key":"4483_CR79","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.clnesp.2023.08.021","volume":"57","author":"G Ramachandran","year":"2023","unstructured":"Ramachandran G, Pottakkat B, Basu S, Mohan P. Effect of probiotics on nutritional status, biochemical parameters, and disease severity in cirrhotic patients referred for liver transplantation-A randomised double blind, placebo-controlled trial. Clin Nutr ESPEN. 2023;57:703\u201310. https:\/\/doi.org\/10.1016\/j.clnesp.2023.08.021. From NLM.","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"4483_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.bbrc.2006.02.080","volume":"343","author":"S Sougioultzis","year":"2006","unstructured":"Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, Pothoulakis C, Kelly CP. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun. 2006;343(1):69\u201376. https:\/\/doi.org\/10.1016\/j.bbrc.2006.02.080. From NLM Medline.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4483_CR81","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.1038\/s41598-021-88497-w","volume":"11","author":"L Barssotti","year":"2021","unstructured":"Barssotti L, Abreu I, Brand\u00e3o ABP, Albuquerque R, Ferreira FG, Salgado MAC, Dias DDS, De Angelis K, Yokota R, Casarini DE, et al. Saccharomyces boulardii modulates oxidative stress and renin angiotensin system attenuating diabetes-induced liver injury in mice. Sci Rep. 2021;11(1):9189. https:\/\/doi.org\/10.1038\/s41598-021-88497-w. From NLM.","journal-title":"Sci Rep"},{"key":"4483_CR82","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3389\/fmicb.2018.02107","volume":"9","author":"D Hill","year":"2018","unstructured":"Hill D, Sugrue I, Tobin C, Hill C, Stanton C, Ross RP. The Lactobacillus casei Group: History and Health Related Applications. Front Microbiol. 2018;9:2107. https:\/\/doi.org\/10.3389\/fmicb.2018.02107. From NLM.","journal-title":"Front Microbiol"},{"issue":"6","key":"4483_CR83","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1007\/s12602-025-10464-y","volume":"17","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Xie W, Duan J, Li F. Probiotic Limosilactobacillus reuteri DSM 17938 Alleviates Acute Liver Injury by Activating the AMPK Signaling via Gut Microbiota-Derived Propionate. Probiotics Antimicrob Proteins. 2025;17(6):5075\u201394. https:\/\/doi.org\/10.1007\/s12602-025-10464-y. From NLM.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"4483_CR84","doi-asserted-by":"publisher","first-page":"134643","DOI":"10.1016\/j.foodchem.2022.134643","volume":"404","author":"Z Lin","year":"2023","unstructured":"Lin Z, Wu J, Wang J, Levesque CL, Ma X. Dietary Lactobacillus reuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism. Food Chem. 2023;404:134643. https:\/\/doi.org\/10.1016\/j.foodchem.2022.134643. (Pt B)From NLM.","journal-title":"Food Chem"},{"issue":"38","key":"4483_CR85","doi-asserted-by":"publisher","first-page":"20930","DOI":"10.1021\/acs.jafc.4c03408","volume":"72","author":"Y Liu","year":"2024","unstructured":"Liu Y, Mei L, Wang L, Tian P, Jin X, Guo M, Lu J, Chen W, Zhang H, Wang G. The Immunomodulatory Effects of Lipoteichoic Acid from Lactobacillus reuteri L1 on RAW264.7 Cells and Mice Vary with Dose. J Agric Food Chem. 2024;72(38):20930\u201343. https:\/\/doi.org\/10.1021\/acs.jafc.4c03408. From NLM.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"4483_CR86","doi-asserted-by":"publisher","first-page":"2430541","DOI":"10.1080\/19490976.2024.2430541","volume":"16","author":"LL Pan","year":"2024","unstructured":"Pan LL, Sun Y, Dong X, Ren Z, Li B, Yang P, Zhang L, Sun J. Infant feces-derived Lactobacillus gasseri FWJL-4 mitigates experimental necrotizing enterocolitis via acetate production. Gut Microbes. 2024;16(1):2430541. https:\/\/doi.org\/10.1080\/19490976.2024.2430541. From NLM.","journal-title":"Gut Microbes"},{"issue":"1","key":"4483_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s44149-024-00125-y","volume":"4","author":"Y Yao","year":"2024","unstructured":"Yao Y, Zhang Y, Song M, Fan J, Feng S, Li J, Wu Z, Zuo B, Tao S, Liu X. Lactobacillus alleviates intestinal epithelial barrier function through GPR43-mediated M2 macrophage polarization. Anim Dis. 2024;4(1):20. https:\/\/doi.org\/10.1186\/s44149-024-00125-y.","journal-title":"Anim Dis"},{"key":"4483_CR88","doi-asserted-by":"publisher","first-page":"107671","DOI":"10.1016\/j.fbio.2025.107671","volume":"73","author":"C Jin","year":"2025","unstructured":"Jin C, Guan C, Yu J, Wang T, Mu G, Tuo Y. Combined effects of Limosilactobacillus reuteri or Lactiplantibacillus plantarum strains with linoleic acid on alleviating inflammation and intestinal barrier dysfunction. Food Bioscience. 2025;73:107671. https:\/\/doi.org\/10.1016\/j.fbio.2025.107671.","journal-title":"Food Bioscience"},{"issue":"1","key":"4483_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13062-024-00462-5","volume":"19","author":"L Zhang","year":"2024","unstructured":"Zhang L, Gong X, Tan J, Zhang R, Li M, Liu C, Wu C, Li X. Lactobacillus reuteri mitigates hepatic ischemia\/reperfusion injury by modulating gut microbiota and metabolism through the Nrf2\/HO-1 signaling. Biol Direct. 2024;19(1):23. https:\/\/doi.org\/10.1186\/s13062-024-00462-5. From NLM.","journal-title":"Biol Direct"},{"issue":"9","key":"4483_CR90","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41418-018-0070-2","volume":"25","author":"Q Hou","year":"2018","unstructured":"Hou Q, Ye L, Liu H, Huang L, Yang Q, Turner JR, Yu Q. Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-22. Cell Death Differ. 2018;25(9):1657\u201370. https:\/\/doi.org\/10.1038\/s41418-018-0070-2. From NLM.","journal-title":"Cell Death Differ"},{"key":"4483_CR91","doi-asserted-by":"publisher","unstructured":"Hitzler SUJ, Fern\u00e1ndez-Fern\u00e1ndez C, Monta\u00f1o DE, Dietschmann A, Gresnigt MS. Microbial adaptive pathogenicity strategies to the host inflammatory environment. FEMS Microbiol Rev. 2025;49. https:\/\/doi.org\/10.1093\/femsre\/fuae032. From NLM.","DOI":"10.1093\/femsre\/fuae032"},{"key":"4483_CR92","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1146\/annurev-immunol-042718-041522","volume":"37","author":"DR Simeonov","year":"2019","unstructured":"Simeonov DR, Marson A. CRISPR-Based Tools in Immunity. Annu Rev Immunol. 2019;37:571\u201397. https:\/\/doi.org\/10.1146\/annurev-immunol-042718-041522. From NLM.","journal-title":"Annu Rev Immunol"},{"key":"4483_CR93","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jare.2020.10.003","volume":"29","author":"D Zhang","year":"2021","unstructured":"Zhang D, Zhang Z, Unver T, Zhang B, CRISPR\/Cas. A powerful tool for gene function study and crop improvement. J Adv Res. 2021;29:207\u201321. https:\/\/doi.org\/10.1016\/j.jare.2020.10.003. From NLM.","journal-title":"J Adv Res"},{"issue":"3","key":"4483_CR94","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.tibtech.2019.09.007","volume":"38","author":"R Kent","year":"2020","unstructured":"Kent R, Dixon N. Contemporary Tools for Regulating Gene Expression in Bacteria. Trends Biotechnol. 2020;38(3):316\u201333. https:\/\/doi.org\/10.1016\/j.tibtech.2019.09.007. From NLM.","journal-title":"Trends Biotechnol"},{"issue":"7","key":"4483_CR95","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, Lu W, Li Y, Huang JD, Xiao Y, et al. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188(7):1842\u2013e18571820. https:\/\/doi.org\/10.1016\/j.cell.2025.02.002. From NLM.","journal-title":"Cell"},{"issue":"6096","key":"4483_CR96","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816\u201321. https:\/\/doi.org\/10.1126\/science.1225829. From NLM.","journal-title":"Science"},{"key":"4483_CR97","doi-asserted-by":"publisher","first-page":"116636","DOI":"10.1016\/j.lfs.2019.116636","volume":"232","author":"D Gupta","year":"2019","unstructured":"Gupta D, Bhattacharjee O, Mandal D, Sen MK, Dey D, Dasgupta A, Kazi TA, Gupta R, Sinharoy S, Acharya K, et al. CRISPR-Cas9 system: A new-fangled dawn in gene editing. Life Sci. 2019;232:116636. https:\/\/doi.org\/10.1016\/j.lfs.2019.116636. From NLM.","journal-title":"Life Sci"},{"key":"4483_CR98","doi-asserted-by":"publisher","DOI":"10.2174\/0115665232376648250312050239","author":"Z Khan","year":"2025","unstructured":"Khan Z, Mumtaz; Gupta S, Mehan S, Sharma T, Kumar M, Maurya PK, Sharma AK, Gupta GD, Narula AS. CRISPR-Cas9: Transforming Functional Genomics, Precision Medicine, and Drug Development - Opportunities, Challenges, and Future Directions. Curr Gene Ther. 2025. https:\/\/doi.org\/10.2174\/0115665232376648250312050239. From NLM.","journal-title":"Curr Gene Ther"},{"key":"4483_CR99","doi-asserted-by":"publisher","unstructured":"An L, Liu Y, Yang Z, Li R, Yin W, Dong H, Li Y, Li Y. Intracellular Delivery of CRISPR\/Cas9 via Living Bacteria to Block Arginine Metabolic Reprogramming and Enhance Tumor Chemotherapy Sensitivity. Adv Funct Mater. 2025;36(8). https:\/\/doi.org\/10.1002\/adfm.202504296.","DOI":"10.1002\/adfm.202504296"},{"issue":"4","key":"4483_CR100","doi-asserted-by":"publisher","first-page":"e0198524","DOI":"10.1128\/aem.01985-24","volume":"91","author":"HC Lin","year":"2025","unstructured":"Lin HC, Hsiao WC, Hsu YC, Lin MC, Hsu CC, Zhang MM. Highly efficient CRISPR-Cas9 base editing in Bifidobacterium with bypass of restriction modification systems. Appl Environ Microbiol. 2025;91(4):e0198524. https:\/\/doi.org\/10.1128\/aem.01985-24. From NLM Medline.","journal-title":"Appl Environ Microbiol"},{"issue":"17","key":"4483_CR101","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gku623","volume":"42","author":"JH Oh","year":"2014","unstructured":"Oh JH, van Pijkeren JP. CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res. 2014;42(17):e131. https:\/\/doi.org\/10.1093\/nar\/gku623. From NLM Medline.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4483_CR102","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11816-010-0161-0","volume":"5","author":"S Kim","year":"2011","unstructured":"Kim S, Kim JS. Targeted genome engineering via zinc finger nucleases. Plant Biotechnol Rep. 2011;5(1):9\u201317. https:\/\/doi.org\/10.1007\/s11816-010-0161-0. From NLM.","journal-title":"Plant Biotechnol Rep"},{"issue":"2","key":"4483_CR103","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/pbi.12465","volume":"14","author":"J Lee","year":"2016","unstructured":"Lee J, Chung JH, Kim HM, Kim DW, Kim H. Designed nucleases for targeted genome editing. Plant Biotechnol J. 2016;14(2):448\u201362. https:\/\/doi.org\/10.1111\/pbi.12465. From NLM.","journal-title":"Plant Biotechnol J"},{"issue":"9","key":"4483_CR104","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1016\/j.ymthe.2024.08.011","volume":"32","author":"NT Tran","year":"2024","unstructured":"Tran NT, Han R. Rapidly evolving genome and epigenome editing technologies. Mol Ther. 2024;32(9):2803\u20136. https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.011. From NLM.","journal-title":"Mol Ther"},{"issue":"39","key":"4483_CR105","doi-asserted-by":"publisher","first-page":"26858","DOI":"10.1021\/acsnano.4c08117","volume":"18","author":"S Qin","year":"2024","unstructured":"Qin S, Liu Y, He G, Yang J, Zeng F, Lu Q, Wang M, He B, Song Y. Spatiotemporal Delivery of Dual Nanobodies by Engineered Probiotics to Reverse Tumor Immunosuppression via Targeting Tumor-Derived Exosomes. ACS Nano. 2024;18(39):26858\u201371. https:\/\/doi.org\/10.1021\/acsnano.4c08117. From NLM.","journal-title":"ACS Nano"},{"issue":"6507","key":"4483_CR106","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/372642a0","volume":"372","author":"Y Choo","year":"1994","unstructured":"Choo Y, Sanchez-Garcia I, Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature. 1994;372(6507):642\u20135. https:\/\/doi.org\/10.1038\/372642a0. From NLM Medline.","journal-title":"Nature"},{"key":"4483_CR107","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1146\/annurev-phyto-080508-081936","volume":"48","author":"J Boch","year":"2010","unstructured":"Boch J, Bonas U. Xanthomonas AvrBs3 family-type III effectors: discovery and function. Annu Rev Phytopathol. 2010;48:419\u201336. https:\/\/doi.org\/10.1146\/annurev-phyto-080508-081936. From NLM.","journal-title":"Annu Rev Phytopathol"},{"issue":"1","key":"4483_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3486","volume":"14","author":"JK Joung","year":"2013","unstructured":"Joung JK, Sander JD. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol. 2013;14(1):49\u201355. https:\/\/doi.org\/10.1038\/nrm3486. From NLM.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5959","key":"4483_CR109","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1178811","volume":"326","author":"J Boch","year":"2009","unstructured":"Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009;326(5959):1509\u201312. https:\/\/doi.org\/10.1126\/science.1178811. From NLM Medline.","journal-title":"Science"},{"issue":"4","key":"4483_CR110","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ymthe.2019.01.014","volume":"27","author":"HX Zhang","year":"2019","unstructured":"Zhang HX, Zhang Y, Yin H. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9. Mol Ther. 2019;27(4):735\u201346. https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.014. From NLM.","journal-title":"Mol Ther"},{"issue":"4","key":"4483_CR111","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/1751-7915.12282","volume":"8","author":"Q Niu","year":"2015","unstructured":"Niu Q, Zheng H, Zhang L, Qin F, Facemire L, Zhang G, Cao F, Zhang KQ, Huang X, Yang J, et al. Knockout of the adp gene related with colonization in Bacillus nematocida B16 using customized transcription activator-like effectors nucleases. Microb Biotechnol. 2015;8(4):681\u201392. https:\/\/doi.org\/10.1111\/1751-7915.12282. From NLM Medline.","journal-title":"Microb Biotechnol"},{"issue":"4","key":"4483_CR112","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jbiosc.2015.02.017","volume":"120","author":"M Aouida","year":"2015","unstructured":"Aouida M, Li L, Mahjoub A, Alshareef S, Ali Z, Piatek A, Mahfouz MM. Transcription activator-like effector nucleases mediated metabolic engineering for enhanced fatty acids production in Saccharomyces cerevisiae. J Biosci Bioeng. 2015;120(4):364\u201371. https:\/\/doi.org\/10.1016\/j.jbiosc.2015.02.017.","journal-title":"J Biosci Bioeng"},{"key":"4483_CR113","doi-asserted-by":"publisher","unstructured":"Tsuboi Y, Sakuma T, Yamamoto T, Horiuchi H, Takahashi F, Igarashi K, Hagihara H, Takimura Y. Gene manipulation in the Mucorales fungus Rhizopus oryzae using TALENs with exonuclease overexpression. FEMS Microbiol Lett. 2022;369(1). https:\/\/doi.org\/10.1093\/femsle\/fnac010. From NLM Medline.","DOI":"10.1093\/femsle\/fnac010"},{"issue":"3","key":"4483_CR114","doi-asserted-by":"publisher","first-page":"e91547","DOI":"10.1371\/journal.pone.0091547","volume":"9","author":"J Jia","year":"2014","unstructured":"Jia J, Jin Y, Bian T, Wu D, Yang L, Terada N, Wu W, Jin S. Bacterial delivery of TALEN proteins for human genome editing. PLoS ONE. 2014;9(3):e91547. https:\/\/doi.org\/10.1371\/journal.pone.0091547. From NLM Medline.","journal-title":"PLoS ONE"},{"issue":"13","key":"4483_CR115","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1021\/acs.accounts.5c00271","volume":"58","author":"M Chen","year":"2025","unstructured":"Chen M, Liu J. Regulating Bacteria-Host Interactions for Disease Intervention by Covalent Conjugation of Bacterial Surface. Acc Chem Res. 2025;58(13):2110\u201323. https:\/\/doi.org\/10.1021\/acs.accounts.5c00271. From NLM Medline.","journal-title":"Acc Chem Res"},{"key":"4483_CR116","doi-asserted-by":"publisher","first-page":"123029","DOI":"10.1016\/j.biomaterials.2024.123029","volume":"317","author":"JN Jiang","year":"2025","unstructured":"Jiang JN, Kong FH, Lei Q, Zhang XZ. Surface-functionalized bacteria: Frontier explorations in next-generation live biotherapeutics. Biomaterials. 2025;317:123029. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.123029. From NLM Medline.","journal-title":"Biomaterials"},{"issue":"15","key":"4483_CR117","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1021\/acs.chemrev.5c00047","volume":"125","author":"AAH Laporte","year":"2025","unstructured":"Laporte AAH, Reek JNH. Supramolecular Materials and Strategies for Bioorthogonal Chemical Transformations. Chem Rev. 2025;125(15):7223\u201374. https:\/\/doi.org\/10.1021\/acs.chemrev.5c00047. From NLM Medline.","journal-title":"Chem Rev"},{"key":"4483_CR118","doi-asserted-by":"publisher","unstructured":"Upadhyay R, Rastogi S, Mishra AK, Yadav S, Yadav AK, Maurya SK. Progress in Strain Promoted Azide-Alkyne Cycloaddition (SPAAC) Reaction and Their Applications. Asian J Org Chem. 2025;14(10). https:\/\/doi.org\/10.1002\/ajoc.202500505.","DOI":"10.1002\/ajoc.202500505"},{"issue":"24","key":"4483_CR119","doi-asserted-by":"publisher","first-page":"1902500","DOI":"10.1002\/advs.201902500","volume":"6","author":"P Pan","year":"2019","unstructured":"Pan P, Fan JX, Wang XN, Wang JW, Zheng DW, Cheng H, Zhang XZ. Bio-Orthogonal Bacterial Reactor for Remission of Heavy Metal Poisoning and ROS Elimination. Adv Sci (Weinh). 2019;6(24):1902500. https:\/\/doi.org\/10.1002\/advs.201902500. From NLM PubMed-not-MEDLINE.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"4483_CR120","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nchembio.720","volume":"7","author":"N Stephanopoulos","year":"2011","unstructured":"Stephanopoulos N, Francis MB. Choosing an effective protein bioconjugation strategy. Nat Chem Biol. 2011;7(12):876\u201384. https:\/\/doi.org\/10.1038\/nchembio.720. From NLM Medline.","journal-title":"Nat Chem Biol"},{"issue":"11","key":"4483_CR121","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1021\/cm062188c","volume":"19","author":"S Liu","year":"2007","unstructured":"Liu S, Wood LF, Ohman DE, Collinson MM. Creating Aligned Arrays of Bacillus Megaterium in Sol\u2009\u2013\u2009Gel Matrixes. Chem Mater. 2007;19(11):2752\u20136. https:\/\/doi.org\/10.1021\/cm062188c.","journal-title":"Chem Mater"},{"issue":"4","key":"4483_CR122","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s12602-019-09628-4","volume":"12","author":"EA Trush","year":"2020","unstructured":"Trush EA, Poluektova EA, Beniashvilli AG, Shifrin OS, Poluektov YM, Ivashkin VT. The Evolution of Human Probiotics: Challenges and Prospects. Probiotics Antimicrob Proteins. 2020;12(4):1291\u20139. https:\/\/doi.org\/10.1007\/s12602-019-09628-4. From NLM.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"8062","key":"4483_CR123","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-025-08717-5","volume":"641","author":"Y Shen","year":"2025","unstructured":"Shen Y, Bai X, Zhang Q, Liang X, Jin X, Zhao Z, Song W, Tan Q, Zhao R, Jia W, et al. Oncolytic virus VG161 in refractory hepatocellular carcinoma. Nature. 2025;641(8062):503\u201311. https:\/\/doi.org\/10.1038\/s41586-025-08717-5. From NLM.","journal-title":"Nature"},{"issue":"21","key":"4483_CR124","doi-asserted-by":"publisher","first-page":"e2412827","DOI":"10.1002\/advs.202412827","volume":"12","author":"YY Zhu","year":"2025","unstructured":"Zhu YY, Dong X, Zhou H, Li ZY, Wang B, Song YP, Liu ZB, Lu X, Zhang YH, Huang Y, et al. Gut Microbiota Colonization in Early Life Influences Susceptibility to Adulthood Hepatic Lipid Accumulation in High-Fat-Diet-Fed Mice. Adv Sci (Weinh). 2025;12(21):e2412827. https:\/\/doi.org\/10.1002\/advs.202412827. From NLM.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"4483_CR125","doi-asserted-by":"publisher","first-page":"113591","DOI":"10.1016\/j.celrep.2023.113591","volume":"43","author":"CJ Yang","year":"2024","unstructured":"Yang CJ, Chang HC, Sung PC, Ge MC, Tang HY, Cheng ML, Cheng HT, Chou HH, Lin CY, Lin WR, et al. Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury. Cell Rep. 2024;43(1):113591. https:\/\/doi.org\/10.1016\/j.celrep.2023.113591. From NLM.","journal-title":"Cell Rep"},{"key":"4483_CR126","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jconrel.2022.06.061","volume":"349","author":"C Xu","year":"2022","unstructured":"Xu C, Ban Q, Wang W, Hou J, Jiang Z. Novel nano-encapsulated probiotic agents: Encapsulate materials, delivery, and encapsulation systems. J Control Release. 2022;349:184\u2013205. https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.061. From NLM.","journal-title":"J Control Release"},{"issue":"8","key":"4483_CR127","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/s41564-025-02057-w","volume":"10","author":"X Zhang","year":"2025","unstructured":"Zhang X, Feng Z, Li H, Yang H, Li L, Zhang C, Dai P, Wang H, Xue H, Wang Y, et al. Ingestible optoelectronic capsules enable bidirectional communication with engineered microbes for controllable therapeutic interventions. Nat Microbiol. 2025;10(8):1841\u201353. https:\/\/doi.org\/10.1038\/s41564-025-02057-w. From NLM Medline.","journal-title":"Nat Microbiol"},{"key":"4483_CR128","doi-asserted-by":"publisher","first-page":"124991","DOI":"10.1016\/j.ijpharm.2024.124991","volume":"668","author":"N F\u00fcl\u00f6pov\u00e1","year":"2025","unstructured":"F\u00fcl\u00f6pov\u00e1 N, Br\u00fcckner K, Musel\u00edk J, Pavlokov\u00e1 S, Franc A. Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials. Int J Pharm. 2025;668:124991. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124991. From NLM.","journal-title":"Int J Pharm"},{"key":"4483_CR129","doi-asserted-by":"publisher","unstructured":"Bajaj JS, Salzman N, Acharya C, Takei H, Kakiyama G, Fagan A, White MB, Gavis EA, Holtz ML, Hayward M, et al. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis. JCI Insight. 2019;4(24). https:\/\/doi.org\/10.1172\/jci.insight.133410. From NLM.","DOI":"10.1172\/jci.insight.133410"},{"issue":"1","key":"4483_CR130","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1038\/s41467-025-59172-9","volume":"16","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Xu Y, Hu Y. Acid-resistant chemotactic DNA micromotors for probiotic delivery in inflammatory bowel disease. Nat Commun. 2025;16(1):3778. https:\/\/doi.org\/10.1038\/s41467-025-59172-9. From NLM.","journal-title":"Nat Commun"},{"key":"4483_CR131","doi-asserted-by":"publisher","unstructured":"Tang Y, Liu W, Zhang J, Juan B, Zhu Y, Zhu L, Zhao Y, Daglia M, Xiao X, He Y. Advances in Intestinal-Targeted Release of Phenolic Compounds. Nutrients. 2025;17(16). https:\/\/doi.org\/10.3390\/nu17162598. From NLM.","DOI":"10.3390\/nu17162598"},{"issue":"Pt 2","key":"4483_CR132","doi-asserted-by":"publisher","first-page":"129287","DOI":"10.1016\/j.ijbiomac.2024.129287","volume":"259","author":"M Mohamadzadeh","year":"2024","unstructured":"Mohamadzadeh M, Fazeli A, Shojaosadati SA. Polysaccharides and proteins-based bionanocomposites for microencapsulation of probiotics to improve stability and viability in the gastrointestinal tract: A review. Int J Biol Macromol. 2024;259(Pt 2):129287. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129287. From NLM.","journal-title":"Int J Biol Macromol"},{"key":"4483_CR133","doi-asserted-by":"publisher","unstructured":"Wang K, Li X, Xu X, Chang J, Sun M, Huang K, Huang S, Jiang H, Wang H, Tan M, et al. AI-driven target screening and microfluidic sonication-assembled oral delivery of fucoxanthin-loaded probiotic vesicles for targeted alleviation of diet-induced obesity. Chem Eng J. 2025;518. https:\/\/doi.org\/10.1016\/j.cej.2025.164598.","DOI":"10.1016\/j.cej.2025.164598"},{"issue":"18","key":"4483_CR134","doi-asserted-by":"publisher","first-page":"e2308728","DOI":"10.1002\/adma.202308728","volume":"36","author":"L Zhu","year":"2024","unstructured":"Zhu L, Yu T, Wang W, Xu T, Geng W, Li N, Zan X. Responsively Degradable Nanoarmor-Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation-Targeted Delivery. Adv Mater. 2024;36(18):e2308728. https:\/\/doi.org\/10.1002\/adma.202308728. From NLM Medline.","journal-title":"Adv Mater"},{"key":"4483_CR135","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2147\/dddt.S419897","volume":"17","author":"C Chen","year":"2023","unstructured":"Chen C, Zhu Z. Recent Advances in the Nanoshells Approach for Encapsulation of Single Probiotics. Drug Des Devel Ther. 2023;17:2763\u201374. https:\/\/doi.org\/10.2147\/dddt.S419897. From NLM.","journal-title":"Drug Des Devel Ther"},{"key":"4483_CR136","doi-asserted-by":"publisher","unstructured":"Zhu L, Wu Y, Chen Y, Chen X, Zan X, Liu Y, Geng W. Microenvironment Self-Adaptive Nanoarmor to Address Adhesion- and Colonization-Related Obstacles in Impaired Intestine Promote Bacteriotherapy Against Parkinson\u2019s Disease. Adv Sci (Weinh). 2026;e10628. https:\/\/doi.org\/10.1002\/advs.202510628. From NLM Publisher.","DOI":"10.1002\/advs.202510628"},{"issue":"4","key":"4483_CR137","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s43018-025-00932-3","volume":"6","author":"L Qiao","year":"2025","unstructured":"Qiao L, Niu L, Wang Z, Deng Z, Di D, Ma X, Zhou Y, Kong D, Wang Q, Yin J, et al. Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nat Cancer. 2025;6(4):612\u201328. https:\/\/doi.org\/10.1038\/s43018-025-00932-3. From NLM.","journal-title":"Nat Cancer"},{"issue":"11","key":"4483_CR138","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.1021\/acsnano.2c11474","volume":"17","author":"T He","year":"2023","unstructured":"He T, Wang L, Gou S, Lu L, Liu G, Wang K, Yang Y, Duan Q, Geng W, Zhao P, et al. Enhanced Immunogenic Cell Death and Antigen Presentation via Engineered Bifidobacterium bifidum to Boost Chemo-immunotherapy. ACS Nano. 2023;17(11):9953\u201371. https:\/\/doi.org\/10.1021\/acsnano.2c11474. From NLM.","journal-title":"ACS Nano"},{"issue":"14","key":"4483_CR139","doi-asserted-by":"publisher","first-page":"14010","DOI":"10.1021\/acsnano.4c18280","volume":"19","author":"X Zhang","year":"2025","unstructured":"Zhang X, Liu R, Chen Y, Wang H, Su W, Song Y, Tan M. Dual-Targeted Nanoparticles Hitchhiking on Lactobacillus rhamnosus Bacterial Ghosts to Alleviate Nonalcoholic Steatohepatitis. ACS Nano. 2025;19(14):14010\u201327. https:\/\/doi.org\/10.1021\/acsnano.4c18280. From NLM.","journal-title":"ACS Nano"},{"key":"4483_CR140","doi-asserted-by":"publisher","first-page":"123694","DOI":"10.1016\/j.biomaterials.2025.123694","volume":"326","author":"X Pan","year":"2026","unstructured":"Pan X, Chen X, Ma Y, Zou J, Lin Y, Zhao X, Wang Y, Tang Y, Gao F. Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation. Biomaterials. 2026;326:123694. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123694. From NLM.","journal-title":"Biomaterials"},{"issue":"2","key":"4483_CR141","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1021\/acsnano.4c16480","volume":"19","author":"C Li","year":"2025","unstructured":"Li C, Feng M, Li B, Feng X, Zhang Y, Wang B. Nanoencapsulation of Living Microbial Cells in Porous Covalent Organic Framework Shells. ACS Nano. 2025;19(2):2890\u20139. https:\/\/doi.org\/10.1021\/acsnano.4c16480. From NLM.","journal-title":"ACS Nano"},{"key":"4483_CR142","doi-asserted-by":"publisher","first-page":"123791","DOI":"10.1016\/j.biomaterials.2025.123791","volume":"327","author":"Z Liu","year":"2026","unstructured":"Liu Z, Feng L, Huang Q, Lu X, Liu H, Wan H. Hierarchical arming of probiotics for improved viability to synergistically alleviate ulcerative colitis. Biomaterials. 2026;327:123791. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123791. From NLM.","journal-title":"Biomaterials"},{"key":"4483_CR143","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jconrel.2025.01.059","volume":"380","author":"H Ji","year":"2025","unstructured":"Ji H, Yan X, Zhang L, Yang L, Xie P, Gu F, Bian S, Wan H, Nie S. Prebiotics empower probiotics with gastrointestinal stress resistance for colon-targeted release to synergistically alleviate colitis. J Control Release. 2025;380:297\u2013316. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.059. From NLM.","journal-title":"J Control Release"},{"issue":"1","key":"4483_CR144","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41522-021-00228-1","volume":"7","author":"M Yao","year":"2021","unstructured":"Yao M, Lu Y, Zhang T, Xie J, Han S, Zhang S, Fei Y, Ling Z, Wu J, Hu Y, et al. Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation. NPJ Biofilms Microbiomes. 2021;7(1):58. https:\/\/doi.org\/10.1038\/s41522-021-00228-1. From NLM.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"4483_CR145","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.2147\/IJN.S513508","volume":"20","author":"Y Deng","year":"2025","unstructured":"Deng Y, Yang B, Yang Z, Xiao H, Zou Y, Zou C, Yang S, Sun X, Wang Y, Bai J, et al. Engineered E. coli OMVs Carrying the Membrane-Binding hGC33 Fragment Precisely Target Liver Cancer and Effectively Treat Tumor. Int J Nanomed. 2025;20:6573\u201390. 10.2147\/IJN.S513508IF: 6.5 Q1 B2 From NLM Medline.","journal-title":"Int J Nanomed"},{"key":"4483_CR146","doi-asserted-by":"publisher","first-page":"111619","DOI":"10.1016\/j.foodhyd.2025.111619","volume":"169","author":"M Wang","year":"2025","unstructured":"Wang M, Zhang S, Liu S, Nian L, Wang S, Cao C. Inulin and metal-phenolic network single-cell encapsulation: Boosting the tolerance and intestinal colonization capability of Bifidobacterium lactis. Food Hydrocolloids. 2025;169:111619. https:\/\/doi.org\/10.1016\/j.foodhyd.2025.111619.","journal-title":"Food Hydrocolloids"},{"issue":"Pt 2","key":"4483_CR147","doi-asserted-by":"publisher","first-page":"135759","DOI":"10.1016\/j.ijbiomac.2024.135759","volume":"280","author":"XC Wang","year":"2024","unstructured":"Wang XC, Xu Y, Jiang W, Luo FX, Zhang D, Wu D, Du YN, Hu JN. Dual-layer probiotic encapsulation using metal phenolic network with gellan gum-tamarind gum coating for colitis treatment. Int J Biol Macromol. 2024;280(Pt 2):135759. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135759. From NLM.","journal-title":"Int J Biol Macromol"},{"key":"4483_CR148","doi-asserted-by":"publisher","unstructured":"Xie Y, Zhang K, Zhu J, Ma L, Zou L, Liu W. Shell-Core Microbeads Loaded with Probiotics: Influence of Lipid Melting Point on Probiotic Activity. Foods. 2024;13(14). https:\/\/doi.org\/10.3390\/foods13142259. From NLM.","DOI":"10.3390\/foods13142259"},{"key":"4483_CR149","doi-asserted-by":"publisher","first-page":"1272850","DOI":"10.3389\/fbioe.2023.1272850","volume":"11","author":"X Ren","year":"2023","unstructured":"Ren X, Su D, Shi D, Xiang X. The improving strategies and applications of nanotechnology-based drugs in hepatocellular carcinoma treatment. Front Bioeng Biotechnol. 2023;11:1272850. https:\/\/doi.org\/10.3389\/fbioe.2023.1272850. From NLM.","journal-title":"Front Bioeng Biotechnol"},{"issue":"8","key":"4483_CR150","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","volume":"40","author":"T Harimoto","year":"2022","unstructured":"Harimoto T, Hahn J, Chen YY, Im J, Zhang J, Hou N, Li F, Coker C, Gray K, Harr N, et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol. 2022;40(8):1259\u201369. https:\/\/doi.org\/10.1038\/s41587-022-01244-y. From NLM.","journal-title":"Nat Biotechnol"},{"key":"4483_CR151","doi-asserted-by":"publisher","first-page":"103270","DOI":"10.1016\/j.cis.2024.103270","volume":"332","author":"R Zhao","year":"2024","unstructured":"Zhao R, Yu T, Li J, Niu R, Liu D, Wang W. Single-cell encapsulation systems for probiotic delivery: Armor probiotics. Adv Colloid Interface Sci. 2024;332:103270. https:\/\/doi.org\/10.1016\/j.cis.2024.103270. From NLM.","journal-title":"Adv Colloid Interface Sci"},{"key":"4483_CR152","doi-asserted-by":"publisher","first-page":"124381","DOI":"10.1016\/j.ijpharm.2024.124381","volume":"660","author":"JM Unagolla","year":"2024","unstructured":"Unagolla JM, Das S, Flanagan R, Oehler M, Menon JU. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives. Int J Pharm. 2024;660:124381. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124381. From NLM Medline.","journal-title":"Int J Pharm"},{"issue":"5","key":"4483_CR153","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/SLA.0000000000006304","volume":"281","author":"M Rela","year":"2025","unstructured":"Rela M, Rammohan A, Rajalingam R, Clavien PA. Portal Hemodynamics in Liver Resection and Transplantation. Ann Surg. 2025;281(5):764\u201372. 1097\/SLA.0000000000006304 From NLM Medline.","journal-title":"Ann Surg"},{"issue":"1","key":"4483_CR154","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/cpt.1588","volume":"107","author":"M Chen","year":"2019","unstructured":"Chen M, Neul C, Schaeffeler E, Frisch F, Winter S, Schwab M, Koepsell H, Hu S, Laufer S, Baker SD, et al. Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1. Clin Pharmacol Ther. 2019;107(1):227\u201337. https:\/\/doi.org\/10.1002\/cpt.1588.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"4483_CR155","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Ramadori P, Pfister D, Seehawer M, Zender L, Heikenwalder M. The immunological and metabolic landscape in primary and metastatic liver cancer. Nat Rev Cancer. 2021;21(9):541\u201357. https:\/\/doi.org\/10.1038\/s41568-021-00383-9. From NLM Medline.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4483_CR156","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1038\/s41467-022-31932-x","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Du M, Yuan Z, Chen Z, Yan F. Spatiotemporal control of engineered bacteria to express interferon-gamma by focused ultrasound for tumor immunotherapy. Nat Commun. 2022;13(1):4468. https:\/\/doi.org\/10.1038\/s41467-022-31932-x. From NLM Medline.","journal-title":"Nat Commun"},{"issue":"1","key":"4483_CR157","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41419-025-07733-7","volume":"16","author":"B Pan","year":"2025","unstructured":"Pan B, Zhang X, Ye D, Yao Y, Zhang Z, Luo Y, Wu H, Wang X, Tang N. Intratumoral Brevibacillus parabrevis enhances antitumor immunity by inhibiting NK cell ferroptosis in hepatocellular carcinoma. Cell Death Dis. 2025;16(1):407. https:\/\/doi.org\/10.1038\/s41419-025-07733-7. From NLM Medline.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4483_CR158","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.chom.2023.11.011","volume":"32","author":"J Yu","year":"2024","unstructured":"Yu J, Zhu P, Shi L, Gao N, Li Y, Shu C, Xu Y, Yu Y, He J, Guo D, et al. Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma. Cell Host Microbe. 2024;32(1):131\u2013e144136. https:\/\/doi.org\/10.1016\/j.chom.2023.11.011. From NLM.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4483_CR159","doi-asserted-by":"publisher","first-page":"2519706","DOI":"10.1080\/19490976.2025.2519706","volume":"17","author":"M Zhang","year":"2025","unstructured":"Zhang M, Huang X, Zhang Y, Yu M, Yuan X, Xu Y, Ma L, Wang X, Xing H. Gut microbial metabolite butyrate suppresses hepatocellular carcinoma growth via CXCL11-dependent enhancement of natural killer cell infiltration. Gut Microbes. 2025;17(1):2519706. https:\/\/doi.org\/10.1080\/19490976.2025.2519706. From NLM.","journal-title":"Gut Microbes"},{"key":"4483_CR160","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13036-019-0189-9","volume":"13","author":"L He","year":"2019","unstructured":"He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, He H, Tang S, Sun Y, Liu F, et al. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng. 2019;13:58. https:\/\/doi.org\/10.1186\/s13036-019-0189-9. From NLM PubMed-not-MEDLINE.","journal-title":"J Biol Eng"},{"issue":"1","key":"4483_CR161","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","volume":"71","author":"J Xiao","year":"2019","unstructured":"Xiao J, Wang F, Wong NK, He J, Zhang R, Sun R, Xu Y, Liu Y, Li W, Koike K, et al. Global liver disease burdens and research trends: Analysis from a Chinese perspective. J Hepatol. 2019;71(1):212\u201321. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.004. From NLM.","journal-title":"J Hepatol"},{"issue":"6","key":"4483_CR162","doi-asserted-by":"publisher","first-page":"e70119","DOI":"10.1111\/liv.70119","volume":"45","author":"F Haedge","year":"2025","unstructured":"Haedge F, Reuken PA, Reissing J, Grosse K, Frissen M, El-Hassani M, Aschenbach R, Teichgraber U, Stallmach A, Bruns T. Surrogate Markers of Intestinal Permeability, Bacterial Translocation and Gut-Vascular Barrier Damage Across Stages of Cirrhosis. Liver Int. 2025;45(6):e70119. https:\/\/doi.org\/10.1111\/liv.70119. From NLM Medline.","journal-title":"Liver Int"},{"key":"4483_CR163","doi-asserted-by":"publisher","unstructured":"Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med. 2019;11(475). https:\/\/doi.org\/10.1126\/scitranslmed.aau7975. From NLM Medline.","DOI":"10.1126\/scitranslmed.aau7975"},{"key":"4483_CR164","doi-asserted-by":"publisher","unstructured":"Tian X, Li R, Jiang Y, Zhao F, Yu Z, Wang Y, Dong Z, Liu P, Li X. Bifidobacterium breve ATCC15700 pretreatment prevents alcoholic liver disease through modulating gut microbiota in mice exposed to chronic alcohol intake. J Funct Foods. 2020;72. https:\/\/doi.org\/10.1016\/j.jff.2020.104045.","DOI":"10.1016\/j.jff.2020.104045"},{"issue":"11","key":"4483_CR165","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3748\/wjg.v30.i11.1556","volume":"30","author":"YC Hu","year":"2024","unstructured":"Hu YC, Ding XC, Liu HJ, Ma WL, Feng XY, Ma LN. Effects of Lactobacillus paracasei N1115 on gut microbial imbalance and liver function in patients with hepatitis B-related cirrhosis. World J Gastroenterol. 2024;30(11):1556\u201371. https:\/\/doi.org\/10.3748\/wjg.v30.i11.1556. From NLM.","journal-title":"World J Gastroenterol"},{"key":"4483_CR166","doi-asserted-by":"publisher","first-page":"857869","DOI":"10.3389\/fphar.2022.857869","volume":"13","author":"C Zou","year":"2022","unstructured":"Zou C, Chen Y, Li H, Li W, Wei J, Li Z, Wang X, Chen T, Huang H. Engineered Bacteria EcN-MT Alleviate Liver Injury in Cadmium-Exposed Mice via its Probiotics Characteristics and Expressing of Metallothionein. Front Pharmacol. 2022;13:857869. https:\/\/doi.org\/10.3389\/fphar.2022.857869. From NLM PubMed-not-MEDLINE.","journal-title":"Front Pharmacol"},{"key":"4483_CR167","doi-asserted-by":"publisher","unstructured":"Guo X, Yin X, Liu Z, Wang J. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. Int J Mol Sci. 2022;23(24). https:\/\/doi.org\/10.3390\/ijms232415489. From NLM.","DOI":"10.3390\/ijms232415489"},{"issue":"8","key":"4483_CR168","doi-asserted-by":"publisher","first-page":"8729","DOI":"10.1021\/acs.jmedchem.5c00402","volume":"68","author":"R Cao","year":"2025","unstructured":"Cao R, Zhang M, Qi M, Zhang Z, Morisseau C, Zhou C, Sun T, Zhuang J, Chen L, Xu C, et al. Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPAR\u03b3 Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases. J Med Chem. 2025;68(8):8729\u201367. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c00402. From NLM.","journal-title":"J Med Chem"},{"key":"4483_CR169","doi-asserted-by":"publisher","unstructured":"Mak AL, Augustijn QJJ, Heymann CJF, Havik S, Verdoes X, Rios-Morales M, Bosmans LA, Verheij J, Meijnikman AS, de Jonge PA, et al. Anaerobutyricum soehngenii Reduces Hepatic Lipogenic Pathways and Increases Intestinal Gluconeogenic Gene Expression in Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) Mice. Int J Mol Sci. 2024;25(6). https:\/\/doi.org\/10.3390\/ijms25063481. From NLM Medline.","DOI":"10.3390\/ijms25063481"},{"issue":"1","key":"4483_CR170","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12934-020-01350-z","volume":"19","author":"L Bai","year":"2020","unstructured":"Bai L, Gao M, Cheng X, Kang G, Cao X, Huang H. Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice. Microb Cell Fact. 2020;19(1):94. https:\/\/doi.org\/10.1186\/s12934-020-01350-z. From NLM Medline.","journal-title":"Microb Cell Fact"},{"issue":"14","key":"4483_CR171","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1021\/acs.jafc.4c07966","volume":"73","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Zhu T, Li Y, Yu B, Tao H, Zhao H, Cui B. Butyrate Regulates Intestinal DNA Virome and Lipopolysaccharide Levels to Prevent High-Fat Diet-Related Liver Damage in Rats. J Agric Food Chem. 2025;73(14):8277\u201389. https:\/\/doi.org\/10.1021\/acs.jafc.4c07966. From NLM Medline.","journal-title":"J Agric Food Chem"},{"key":"4483_CR172","doi-asserted-by":"publisher","unstructured":"Coppola S, Avagliano C, Calignano A, Berni Canani R. The Protective Role of Butyrate against Obesity and Obesity-Related Diseases. Molecules. 2021;26(3). https:\/\/doi.org\/10.3390\/molecules26030682. From NLM Medline.","DOI":"10.3390\/molecules26030682"},{"issue":"4","key":"4483_CR173","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.26599\/FSHW.2022.9250172","volume":"13","author":"H Li","year":"2024","unstructured":"Li H, Cheng S, Wang Y, Sun Y, Zhang J, Sun M, Man C, Zhang Y, Jiang Y. Lactobacillus plantarum J26 alleviates alcohol-induced oxidative liver injury by regulating the Nrf2 signaling pathway. Food Sci Hum Wellness. 2024;13(4):2068\u201378. https:\/\/doi.org\/10.26599\/FSHW.2022.9250172.","journal-title":"Food Sci Hum Wellness"},{"key":"4483_CR174","doi-asserted-by":"publisher","first-page":"1129904","DOI":"10.3389\/fmicb.2023.1129904","volume":"14","author":"SJ Yoon","year":"2023","unstructured":"Yoon SJ, Yu JS, Min BH, Gupta H, Won SM, Park HJ, Han SH, Kim BY, Kim KH, Kim BK, et al. Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Front Microbiol. 2023;14:1129904. https:\/\/doi.org\/10.3389\/fmicb.2023.1129904. From NLM.","journal-title":"Front Microbiol"},{"issue":"1","key":"4483_CR175","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.gendis.2024.101215","volume":"12","author":"J Ren","year":"2025","unstructured":"Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X, Tan M, Huang A, Chen J. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes Dis. 2025;12(1):101215. https:\/\/doi.org\/10.1016\/j.gendis.2024.101215. From NLM PubMed-not-MEDLINE.","journal-title":"Genes Dis"},{"issue":"9","key":"4483_CR176","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3748\/wjg.v28.i9.881","volume":"28","author":"HJ Zhao","year":"2022","unstructured":"Zhao HJ, Hu YF, Han QJ, Zhang J. Innate and adaptive immune escape mechanisms of hepatitis B virus. World J Gastroenterol. 2022;28(9):881\u201396. https:\/\/doi.org\/10.3748\/wjg.v28.i9.881. From NLM Medline.","journal-title":"World J Gastroenterol"},{"issue":"14","key":"4483_CR177","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3748\/wjg.v28.i14.1405","volume":"28","author":"MA Odenwald","year":"2022","unstructured":"Odenwald MA, Paul S. Viral hepatitis: Past, present, and future. World J Gastroenterol. 2022;28(14):1405\u201329. https:\/\/doi.org\/10.3748\/wjg.v28.i14.1405. From NLM.","journal-title":"World J Gastroenterol"},{"key":"4483_CR178","doi-asserted-by":"publisher","unstructured":"Mak LY, Lok AS. F. Update on combination therapies against HBV in clinical investigations. Antiviral Res. 2025;106321. https:\/\/doi.org\/10.1016\/j.antiviral.2025.106321. From NLM.","DOI":"10.1016\/j.antiviral.2025.106321"},{"issue":"1","key":"4483_CR179","doi-asserted-by":"publisher","first-page":"2500056","DOI":"10.1080\/19490976.2025.2500056","volume":"17","author":"NS Kamble","year":"2025","unstructured":"Kamble NS, Thomas S, Madaan T, Ehsani N, Sange S, Tucker K, Muhumure A, Kunkler S. Kotagiri, N. Engineered bacteria as an orally administered anti-viral treatment and immunization system. Gut Microbes. 2025;17(1):2500056. https:\/\/doi.org\/10.1080\/19490976.2025.2500056. From NLM Medline.","journal-title":"Gut Microbes"},{"key":"4483_CR180","doi-asserted-by":"crossref","unstructured":"Liu R, Zhang J, Wang K, Qian Y. Clinical effectiveness of combined Bifidobacterium live bacteria preparation and entecavir therapy in the management of Hepatitis B cirrhosis. Trop J Pharm Res 2024;23(2):379\u2013386.","DOI":"10.4314\/tjpr.v23i2.18"},{"issue":"1","key":"4483_CR181","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","volume":"18","author":"R Wang","year":"2021","unstructured":"Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol. 2021;18(1):4\u201317. https:\/\/doi.org\/10.1038\/s41423-020-00592-6. From NLM.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"4483_CR182","doi-asserted-by":"publisher","first-page":"e2406445","DOI":"10.1002\/advs.202406445","volume":"12","author":"J Xiao","year":"2025","unstructured":"Xiao J, Hou Y, Luo X, Zhu Y, Li W, Li B, Zhou L, Chen X, Guo Y, Zhang X, et al. Clostridium Scindens Protects Against Vancomycin-Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR-FGF15\/19 Signaling. Adv Sci (Weinh). 2025;12(5):e2406445. https:\/\/doi.org\/10.1002\/advs.202406445. From NLM Medline.","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"4483_CR183","doi-asserted-by":"publisher","first-page":"623","DOI":"10.14670\/hh-18-669","volume":"39","author":"J Song","year":"2024","unstructured":"Song J, Dai J, Chen X, Ding F, Ding Y, Ma L, Zhang L. Bifidobacterium mitigates autoimmune hepatitis by regulating IL-33-induced Treg\/Th17 imbalance via the TLR2\/4 signaling pathway. Histol Histopathol. 2024;39(5):623\u201332. https:\/\/doi.org\/10.14670\/hh-18-669. From NLM.","journal-title":"Histol Histopathol"},{"issue":"3","key":"4483_CR184","doi-asserted-by":"publisher","first-page":"e14001","DOI":"10.1111\/apha.14001","volume":"238","author":"D Ciocan","year":"2023","unstructured":"Ciocan D, Elinav E. Engineering bacteria to modulate host metabolism. Acta Physiol (Oxf). 2023;238(3):e14001. https:\/\/doi.org\/10.1111\/apha.14001. From NLM Medline.","journal-title":"Acta Physiol (Oxf)"},{"key":"4483_CR185","doi-asserted-by":"publisher","first-page":"108663","DOI":"10.1016\/j.biotechadv.2025.108663","volume":"84","author":"JP Carvalho","year":"2025","unstructured":"Carvalho JP, Moreno DS, Domingues L. Genetic engineering of Saccharomyces boulardii: Tools, strategies and advances for enhanced probiotic and therapeutic applications. Biotechnol Adv. 2025;84:108663. https:\/\/doi.org\/10.1016\/j.biotechadv.2025.108663. From NLM Medline.","journal-title":"Biotechnol Adv"},{"key":"4483_CR186","doi-asserted-by":"publisher","first-page":"115663","DOI":"10.1016\/j.addr.2025.115663","volume":"225","author":"NY Brittain","year":"2025","unstructured":"Brittain NY, Finbloom JA. Bioinspired approaches to encapsulate and deliver bacterial live biotherapeutic products. Adv Drug Deliv Rev. 2025;225:115663. https:\/\/doi.org\/10.1016\/j.addr.2025.115663. From NLM Medline.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"4483_CR187","doi-asserted-by":"publisher","first-page":"e70305","DOI":"10.1111\/1751-7915.70305","volume":"19","author":"Y Zhu","year":"2026","unstructured":"Zhu Y, Lv L, Du B, Zhao M. Next-Generation Microencapsulation Technologies for Probiotic Protection and Precision Delivery. Microb Biotechnol. 2026;19(2):e70305. https:\/\/doi.org\/10.1111\/1751-7915.70305. From NLM Medline.","journal-title":"Microb Biotechnol"},{"key":"4483_CR188","doi-asserted-by":"publisher","unstructured":"Zi G, Zhou W, Zhou L, Wang L, Zheng P, Wei S. Engineered Bacteria-Nano Hybrid System: The Intelligent Drug Factory for Next-Generation Cancer Immunotherapy. Pharmaceutics. 2025;17(10). https:\/\/doi.org\/10.3390\/pharmaceutics17101349. From NLM PubMed-not-MEDLINE.","DOI":"10.3390\/pharmaceutics17101349"},{"key":"4483_CR189","doi-asserted-by":"publisher","first-page":"0955","DOI":"10.34133\/research.0955","volume":"8","author":"J Wu","year":"2025","unstructured":"Wu J, Wu L, Liu R, Xuan L, Qian J, Fang C, Wang H, Guo J, Du L, Miao Y, et al. Fabrication of Single-Bacterium Microgel with Gas-Shearing Strategy for Precision Probiotic Delivery in IBD Therapy. Res (Wash D C). 2025;8:0955. https:\/\/doi.org\/10.34133\/research.0955. From NLM PubMed-not-MEDLINE.","journal-title":"Res (Wash D C)"},{"issue":"12","key":"4483_CR190","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18(12):727\u201343. https:\/\/doi.org\/10.1038\/s41568-018-0070-z. From NLM Medline.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4483_CR191","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/1078-0432.CCR-11-2121","volume":"18","author":"DT Le","year":"2012","unstructured":"Le DT, Brockstedt DG, Nir-Paz R, Hampl J, Mathur S, Nemunaitis J, Sterman DH, Hassan R, Lutz E, Moyer B, et al. A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res. 2012;18(3):858\u201368. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2121. From NLM Medline.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4483_CR192","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-023-01375-x","volume":"8","author":"N Zhao","year":"2023","unstructured":"Zhao N, Song Y, Xie X, Zhu Z, Duan C, Nong C, Wang H, Bao R. Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development. Signal Transduct Target Ther. 2023;8(1):112. https:\/\/doi.org\/10.1038\/s41392-023-01375-x. From NLM Medline.","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"4483_CR193","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","volume":"29","author":"JJ Luke","year":"2023","unstructured":"Luke JJ, Piha-Paul SA, Medina T, Verschraegen CF, Varterasian M, Brennan AM, Riese RJ, Sokolovska A, Strauss J, Hava DL, et al. Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies. Clin Cancer Res. 2023;29(13):2435\u201344. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0118. From NLM Medline.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4483_CR194","doi-asserted-by":"publisher","first-page":"e2410011","DOI":"10.1002\/advs.202410011","volume":"12","author":"H Xu","year":"2025","unstructured":"Xu H, Wang Y, Liu G, Zhu Z, Shahbazi MA, Reis RL, Kundu SC, Shi X, Zu M, Xiao B. Nano-Armed Limosilactobacillus reuteri for Enhanced Photo-Immunotherapy and Microbiota Tryptophan Metabolism against Colorectal Cancer. Adv Sci (Weinh). 2025;12(7):e2410011. https:\/\/doi.org\/10.1002\/advs.202410011. From NLM.","journal-title":"Adv Sci (Weinh)"},{"key":"4483_CR195","doi-asserted-by":"publisher","unstructured":"Oh JH, Schueler KL, Stapleton DS, Alexander LM, Yen CE, Keller MP, Attie AD, van Pijkeren JP. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity. mSphere. 2020;5(3). https:\/\/doi.org\/10.1128\/mSphere.00183-20. From NLM Medline.","DOI":"10.1128\/mSphere.00183-20"},{"key":"4483_CR196","doi-asserted-by":"publisher","unstructured":"Zhang Y, Huang H, Luo C, Zhang X, Chen Y, Yue F, Xie B, Chen T, Zou C. The Next-Generation Probiotic E. coli 1917-pSK18a-MT Ameliorates Cadmium-Induced Liver Injury by Surface Display of Metallothionein and Modulation of Gut Microbiota. Nutrients. 2024;16(10). https:\/\/doi.org\/10.3390\/nu16101468. From NLM Medline.","DOI":"10.3390\/nu16101468"},{"key":"4483_CR197","doi-asserted-by":"crossref","unstructured":"Giacca G, Buccarello G, Breggion S, Bresesti C, Beretta S, Kerzel T, Notaro M, Vallorini A, Omer-Javed A, Montaldo E et al. 1007\u2005Bridging species barriers: a humanized model for macrophage-directed in vivo gene therapy in liver metastases. In Regular and Young Investigator Award Abstracts, 2025;13(Suppl 2):A1138.","DOI":"10.1136\/jitc-2025-SITC2025.1007"},{"key":"4483_CR198","doi-asserted-by":"publisher","first-page":"1404353","DOI":"10.3389\/frmbi.2024.1404353","volume":"3","author":"L Daharsh","year":"2024","unstructured":"Daharsh L, Lohani SC, Ramer-Tait AE, Li Q. Characterization of double humanized BLT-mice with stable engraftment of a human gut bacterial microbiome. Front Microbiomes. 2024;3:1404353. https:\/\/doi.org\/10.3389\/frmbi.2024.1404353. From NLM PubMed-not-MEDLINE.","journal-title":"Front Microbiomes"},{"issue":"1","key":"4483_CR199","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.1038\/s41467-025-63627-4","volume":"16","author":"DP Byrom","year":"2025","unstructured":"Byrom DP, Darlington AP. S. Genetic controllers for enhancing the evolutionary longevity of synthetic gene circuits in bacteria. Nat Commun. 2025;16(1):8590. https:\/\/doi.org\/10.1038\/s41467-025-63627-4. From NLM Medline.","journal-title":"Nat Commun"},{"issue":"1","key":"4483_CR200","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","volume":"13","author":"AG Rottinghaus","year":"2022","unstructured":"Rottinghaus AG, Ferreiro A, Fishbein SRS, Dantas G, Moon TS. Genetically stable CRISPR-based kill switches for engineered microbes. Nat Commun. 2022;13(1):672. https:\/\/doi.org\/10.1038\/s41467-022-28163-5. From NLM Medline.","journal-title":"Nat Commun"},{"key":"4483_CR201","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-food-030216-030256","volume":"8","author":"B Sola-Oladokun","year":"2017","unstructured":"Sola-Oladokun B, Culligan EP, Sleator RD. Engineered Probiotics: Applications and Biological Containment. Annu Rev Food Sci Technol. 2017;8:353\u201370. https:\/\/doi.org\/10.1146\/annurev-food-030216-030256. From NLM Medline.","journal-title":"Annu Rev Food Sci Technol"},{"key":"4483_CR202","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.2147\/IJN.S516523","volume":"20","author":"X Chang","year":"2025","unstructured":"Chang X, Liu X, Wang X, Ma L, Liang J, Li Y. Recent Advances in Spatiotemporal Manipulation of Engineered Bacteria for Precision Cancer Therapy. Int J Nanomed. 2025;20:5859\u201372. 2147\/IJN.S516523 From NLM Medline.","journal-title":"Int J Nanomed"},{"issue":"6","key":"4483_CR203","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1086\/315497","volume":"181","author":"C Clairmont","year":"2000","unstructured":"Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, Bermudes D, Brecher SM, Margitich D, Turnier J, et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis. 2000;181(6):1996\u20132002. 10.1086\/315497IF: 4.5 Q1 B2 From NLM Medline.","journal-title":"J Infect Dis"},{"key":"4483_CR204","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ymben.2025.06.009","volume":"91","author":"C Maneira","year":"2025","unstructured":"Maneira C, Becker S, Chamas A, Lackner G. A multilayered biocontainment system for laboratory and probiotic yeast. Metab Eng. 2025;91:442\u201354. https:\/\/doi.org\/10.1016\/j.ymben.2025.06.009. From NLM Medline.","journal-title":"Metab Eng"},{"issue":"4","key":"4483_CR205","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/EBC20160013","volume":"60","author":"L Torres","year":"2016","unstructured":"Torres L, Kruger A, Csibra E, Gianni E, Pinheiro VB. Synthetic biology approaches to biological containment: pre-emptively tackling potential risks. Essays Biochem. 2016;60(4):393\u2013410. 10.1042\/EBC20160013IF: 5.7 Q1 B2 From NLM Medline.","journal-title":"Essays Biochem"},{"issue":"1","key":"4483_CR206","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/s41467-024-45893-w","volume":"15","author":"N Hayashi","year":"2024","unstructured":"Hayashi N, Lai Y, Fuerte-Stone J, Mimee M, Lu TK. Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements. Nat Commun. 2024;15(1):2096. https:\/\/doi.org\/10.1038\/s41467-024-45893-w. From NLM Medline.","journal-title":"Nat Commun"},{"key":"4483_CR207","doi-asserted-by":"publisher","unstructured":"Sher AA, Whitehead-Tillery CE, Peer AM, Bell JA, Vocelle DB, Dippel JT, Zhang L, Mansfield LS. Dynamic Spread of Antibiotic Resistance Determinants by Conjugation to a Human-Derived Gut Microbiota in a Transplanted Mouse Model. Antibiot (Basel). 2025;14(2). https:\/\/doi.org\/10.3390\/antibiotics14020152. From NLM PubMed-not-MEDLINE.","DOI":"10.3390\/antibiotics14020152"},{"issue":"3","key":"4483_CR208","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.synbio.2024.04.010","volume":"9","author":"H Guo","year":"2024","unstructured":"Guo H, Tian R, Wu Y, Lv X, Li J, Liu L, Du G, Chen J, Liu Y. Facilitating stable gene integration expression and copy number amplification in Bacillus subtilis through a reversible homologous recombination switch. Synth Syst Biotechnol. 2024;9(3):577\u201385. https:\/\/doi.org\/10.1016\/j.synbio.2024.04.010. From NLM PubMed-not-MEDLINE.","journal-title":"Synth Syst Biotechnol"},{"key":"4483_CR209","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymben.2019.06.011","volume":"55","author":"R Zhang","year":"2019","unstructured":"Zhang R, Yang Y, Wang J, Lin Y, Yan Y. Synthetic symbiosis combining plasmid displacement enables rapid construction of phenotype-stable strains. Metab Eng. 2019;55:85\u201391. https:\/\/doi.org\/10.1016\/j.ymben.2019.06.011. From NLM Medline.","journal-title":"Metab Eng"},{"issue":"1","key":"4483_CR210","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41467-023-44531-1","volume":"15","author":"DR George","year":"2024","unstructured":"George DR, Danciu M, Davenport PW, Lakin MR, Chappell J, Frow E. K. A bumpy road ahead for genetic biocontainment. Nat Commun. 2024;15(1):650. https:\/\/doi.org\/10.1038\/s41467-023-44531-1. From NLM PubMed-not-MEDLINE.","journal-title":"Nat Commun"},{"issue":"7","key":"4483_CR211","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nbt840","volume":"21","author":"L Steidler","year":"2003","unstructured":"Steidler L, Neirynck S, Huyghebaert N, Snoeck V, Vermeire A, Goddeeris B, Cox E, Remon JP, Remaut E. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat Biotechnol. 2003;21(7):785\u20139. https:\/\/doi.org\/10.1038\/nbt840. From NLM Medline.","journal-title":"Nat Biotechnol"},{"key":"4483_CR212","doi-asserted-by":"publisher","unstructured":"Xu X, Zhang C, Tang G, Wang N, Feng Y. Updated Insights into Probiotics and Hepatobiliary Diseases. Biomedicines. 2024;12(3). https:\/\/doi.org\/10.3390\/biomedicines12030515. From NLM PubMed-not-MEDLINE.","DOI":"10.3390\/biomedicines12030515"},{"issue":"7","key":"4483_CR213","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41551-022-00871-9","volume":"6","author":"A Cubillos-Ruiz","year":"2022","unstructured":"Cubillos-Ruiz A, Alcantar MA, Donghia NM, Cardenas P, Avila-Pacheco J, Collins JJ. An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis. Nat Biomed Eng. 2022;6(7):910\u201321. https:\/\/doi.org\/10.1038\/s41551-022-00871-9. From NLM Medline.","journal-title":"Nat Biomed Eng"},{"issue":"1\u20132","key":"4483_CR214","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ijfoodmicro.2010.06.018","volume":"142","author":"KC Lee","year":"2010","unstructured":"Lee KC, Liu CF, Lin TH, Pan TM. Safety and risk assessment of the genetically modified Lactococci on rats intestinal bacterial flora. Int J Food Microbiol. 2010;142(1\u20132):164\u20139. https:\/\/doi.org\/10.1016\/j.ijfoodmicro.2010.06.018. From NLM Medline.","journal-title":"Int J Food Microbiol"},{"issue":"5","key":"4483_CR215","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/gutjnl-2024-334501","volume":"74","author":"CH Tseng","year":"2025","unstructured":"Tseng CH, Wong S, Yu J, Lee YY, Terauchi J, Lai HC, Luo JC, Kao CY, Yu SL, Liou JM, et al. Development of live biotherapeutic products: a position statement of Asia-Pacific Microbiota Consortium. Gut. 2025;74(5):706\u201313. https:\/\/doi.org\/10.1136\/gutjnl-2024-334501. From NLM Medline.","journal-title":"Gut"},{"issue":"1","key":"4483_CR216","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41467-020-15508-1","volume":"11","author":"MR Charbonneau","year":"2020","unstructured":"Charbonneau MR, Isabella VM, Li N, Kurtz CB. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat Commun. 2020;11(1):1738. https:\/\/doi.org\/10.1038\/s41467-020-15508-1. From NLM Medline.","journal-title":"Nat Commun"},{"issue":"5","key":"4483_CR217","doi-asserted-by":"publisher","first-page":"e0239424","DOI":"10.1128\/aem.02394-24","volume":"91","author":"L Brunelli","year":"2025","unstructured":"Brunelli L, Perotti S, Gargari G, De Vitis V, Mantegazza G, Ferrari R, Minuzzo M, Pierallini E, Ricci G, Fiore W, et al. Genetic and phenotypic stability of Lacticaseibacillus paracasei DG (DSM 34154) over 10 years of industrial production. Appl Environ Microbiol. 2025;91(5):e0239424. https:\/\/doi.org\/10.1128\/aem.02394-24. From NLM Medline.","journal-title":"Appl Environ Microbiol"},{"key":"4483_CR218","doi-asserted-by":"publisher","unstructured":"Hua Z, Liu S, Yang G, Hou X, Fang Y. Next-generation probiotics: innovations in safety assessments. Curr Opin Food Sci. 2025;61. https:\/\/doi.org\/10.1016\/j.cofs.2024.101238.","DOI":"10.1016\/j.cofs.2024.101238"},{"issue":"6","key":"4483_CR219","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1080\/1040841X.2024.2311653","volume":"50","author":"AM Mowday","year":"2024","unstructured":"Mowday AM, van de Laak JM, Fu Z, Henare KL, Dubois L, Lambin P, Theys J, Patterson AV. Tumor-targeting bacteria as immune stimulants - the future of cancer immunotherapy? Crit Rev Microbiol. 2024;50(6):955\u201370. .2024.2311653 From NLM Medline.","journal-title":"Crit Rev Microbiol"},{"issue":"36","key":"4483_CR220","doi-asserted-by":"publisher","first-page":"e2404069","DOI":"10.1002\/advs.202404069","volume":"11","author":"L Wu","year":"2024","unstructured":"Wu L, Li L, Qiao L, Li C, Zhang S, Yin X, Du Z, Sun Y, Qiu J, Chang X, et al. Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity. Adv Sci (Weinh). 2024;11(36):e2404069. https:\/\/doi.org\/10.1002\/advs.202404069. From NLM Medline.","journal-title":"Adv Sci (Weinh)"},{"key":"4483_CR221","doi-asserted-by":"publisher","first-page":"1569348","DOI":"10.3389\/frmbi.2025.1569348","volume":"4","author":"R Slijkerman","year":"2025","unstructured":"Slijkerman R, van Dijk R, Mohieddin N, Ciarlante I, de Jong A, Schuler MM. Chemistry, manufacturing, and controls for live microbial products: addressing classification challenges and enhancing process validation. Front Microbiomes. 2025;4:1569348. https:\/\/doi.org\/10.3389\/frmbi.2025.1569348. From NLM PubMed-not-MEDLINE.","journal-title":"Front Microbiomes"},{"issue":"1","key":"4483_CR222","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12876-024-03356-y","volume":"24","author":"Y Pan","year":"2024","unstructured":"Pan Y, Yang Y, Wu J, Zhou H, Yang C. Efficacy of probiotics, prebiotics, and synbiotics on liver enzymes, lipid profiles, and inflammation in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. BMC Gastroenterol. 2024;24(1):283. https:\/\/doi.org\/10.1186\/s12876-024-03356-y. From NLM Medline.","journal-title":"BMC Gastroenterol"},{"key":"4483_CR223","doi-asserted-by":"publisher","unstructured":"Sharma D, Patel D, Mandal P. In Vitro, In Vivo, and In Silico Investigation of Synbiotic-Mediated Activation of PPAR-alpha Curtails Nonalcoholic Steatohepatitis (NASH) in Wistar Rats by Inhibiting PNPLA3\/SREBP1-c Lead Inflammatory Injury of Hepatic Cells. Mediators Inflamm. 2025;2025(9948679). https:\/\/doi.org\/10.1155\/mi\/9948679. From NLM Medline.","DOI":"10.1155\/mi\/9948679"},{"issue":"8","key":"4483_CR224","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41575-022-00612-y","volume":"19","author":"A Shaukat","year":"2022","unstructured":"Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. 2022;19(8):521\u201331. https:\/\/doi.org\/10.1038\/s41575-022-00612-y. From NLM Medline.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4483_CR225","doi-asserted-by":"publisher","unstructured":"Ye W, Chen Z, He Z, Gong H, Zhang J, Sun J, Yuan S, Deng J, Liu Y, Zeng A. Lactobacillus plantarum-Derived Postbiotics Ameliorate Acute Alcohol-Induced Liver Injury by Protecting Cells from Oxidative Damage, Improving Lipid Metabolism, and Regulating Intestinal Microbiota. Nutrients. 2023;15(4). https:\/\/doi.org\/10.3390\/nu15040845. From NLM Medline.","DOI":"10.3390\/nu15040845"},{"issue":"8","key":"4483_CR226","doi-asserted-by":"publisher","first-page":"101456","DOI":"10.1016\/j.jhepr.2025.101456","volume":"7","author":"Z Xun","year":"2025","unstructured":"Xun Z, Yao X, Lin C, Yang X, Zhang Y, Yang X, He Y, Jiang R, Lan Y, Ye Y, et al. A novel therapy targeting the gut-liver axis for chronic hepatitis B: Ursodeoxycholic acid plus Bifidobacterium. JHEP Rep. 2025;7(8):101456. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101456. From NLM PubMed-not-MEDLINE.","journal-title":"JHEP Rep"},{"key":"4483_CR227","doi-asserted-by":"publisher","unstructured":"Zhong X, Wang Y, Song C, Song X, Zhang Y, Cao L, Skirtach AG, Song S, Tan M, Su W. Engineered liver-targeted probiotic nanovesicles overcome oral absorption barriers to cure alcoholic liver disease. Chem Eng J. 2025;522. https:\/\/doi.org\/10.1016\/j.cej.2025.167270.","DOI":"10.1016\/j.cej.2025.167270"},{"key":"4483_CR228","doi-asserted-by":"publisher","unstructured":"Martinez-Ruiz S, Badia J, Baldoma L. Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats. Nutrients. 2025;17(19). https:\/\/doi.org\/10.3390\/nu17193066. From NLM Medline.","DOI":"10.3390\/nu17193066"},{"key":"4483_CR229","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.2147\/IJN.S453709","volume":"19","author":"M Yang","year":"2024","unstructured":"Yang M, Chen W, Gupta D, Mei C, Yang Y, Zhao B, Qiu L, Chen J. Nanoparticle\/Engineered Bacteria Based Triple-Strategy Delivery System for Enhanced Hepatocellular Carcinoma Cancer Therapy. Int J Nanomed. 2024;19:3827\u201346. 10.2147\/IJN.S453709IF: 6.5 Q1 B2 From NLM Medline.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4483_CR230","doi-asserted-by":"publisher","first-page":"2517377","DOI":"10.1080\/19490976.2025.2517377","volume":"17","author":"M Maor","year":"2025","unstructured":"Maor M, Levy Barazany H, Kolodkin-Gal I. The ladder of regulatory stringency and balance: an application to the US FDA\u2019s regulation of bacterial live therapeutics. Gut Microbes. 2025;17(1):2517377. https:\/\/doi.org\/10.1080\/19490976.2025.2517377. From NLM Medline.","journal-title":"Gut Microbes"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04483-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:52:17Z","timestamp":1781650337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04483-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":230,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4483"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04483-2","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"569"}}